2022

Ziff, O.J., Ashton, N.J., Mehta, P.R., Brown, R., Athauda, D., Heaney, J., ...Checkley, A.M. (2022). Amyloid processing in COVID-19 associated neurological syndromes.. Journal of Neurochemistry, doi:10.1111/jnc.15585
Keuss, S.E., Coath, W., Nicholas, J.M., Poole, T., Barnes, J., Cash, D.M., ...Buchanan, S.M. (2022). Associations of β-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort. Neurology, doi:10.1212/WNL.0000000000200524
Zetterberg, H., Schott, J.M. (2022). Blood biomarkers for Alzheimer's disease and related disorders.. Acta Neurologica Scandinavica, doi:10.1111/ane.13628
Sliz, E., Shin, J., Ahmad, S., Williams, D.M., Frenzel, S., Gauß, F., ...Hu, Y.-.H. (2022). Circulating Metabolome and White Matter Hyperintensities in Females and Males.. Circulation, doi:10.1161/CIRCULATIONAHA.121.056892
Keshavan, A., O'Shea, F., Chapman, M.D., Hart, M.S., Lunn, M.P., Paterson, R.W., ...Zetterberg, H. (2022). CSF biomarkers for dementia.. Practical Neurology, doi:10.1136/practneurol-2021-003310
Wilson, K.M., Katona, E., Glaria, I., Carcolé, M., Swift, I.J., Sogorb-Esteve, A., ...Keshavan, A. (2022). Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry, doi:10.1136/jnnp-2021-328710
Harris, M.J., Lane, C.A., Coath, W., Malone, I.B., Cash, D.M., Barnes, J., ...Schott, J.M. (2022). Familial British dementia: a clinical and multi-modal imaging case study. Journal of Neurology, doi:10.1007/s00415-022-11036-8
Bellenguez, C., Küçükali, F., Jansen, I.E., Kleineidam, L., Moreno-Grau, S., Amin, N., ...Andrade, V. (2022). New insights into the genetic etiology of Alzheimer's disease and related dementias. Nature Genetics, 54 412-436. doi:10.1038/s41588-022-01024-z
Janahi, M., Aksman, L.M., Schott, J., Altmann, A. (2022). Nomograms of Human Hippocampal Volume Shifted by Polygenic Scores. .
Webber, M., Falconer, D., AlFarih, M., Joy, G., Chan, F., Davie, C., ...Bhuva, A. (2022). Study protocol: MyoFit46-the cardiac sub-study of the MRC National Survey of Health and Development. BMC Cardiovascular Disorders, 22 doi:10.1186/s12872-022-02582-0
Ibañez, K., Polke, J., Hagelstrom, R.T., Dolzhenko, E., Pasko, D., Thomas, E.R.A., ...WGS for Neurological Diseases, G.r.o.u.p. (2022). Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study. The Lancet Neurology, 21 (3), 234-245. doi:10.1016/S1474-4422(21)00462-2

2021

James, S.-.N., Nicholas, J.M., Lane, C.A., Parker, T.D., Lu, K., Keshavan, A., ...Wong, A. (2021). A population-based study of head injury, cognitive function and pathological markers.. Ann Clin Transl Neurol, doi:10.1002/acn3.51331
Lalli, G., Schott, J.M., Hardy, J., De Strooper, B. (2021). Aducanumab: a new phase in therapeutic development for Alzheimer’s disease?. EMBO Molecular Medicine, 13 doi:10.15252/emmm.202114781
Benjamin, L.A., Paterson, R.W., Moll, R., Pericleous, C., Brown, R., Mehta, P.R., ...Checkley, A.M. (2021). Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study. EClinicalMedicine, doi:10.1016/j.eclinm.2021.101070
Pemberton, H.G., Goodkin, O., Prados, F., Das, R.K., Vos, S.B., Moggridge, J., ...Schmitt, A. (2021). Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study.. Eur Radiol, doi:10.1007/s00330-020-07455-8
Verdi, S., Marquand, A.F., Schott, J.M., Cole, J.H. (2021). Beyond the average patient: how neuroimaging models can address heterogeneity in dementia. Brain, doi:10.1093/brain/awab165
Banerjee, G., Forsgard, N., Ambler, G., Keshavan, A., Paterson, R.W., Foiani, M.S., ...Lunn, M.P. (2021). Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.. Journal of Neurology, doi:10.1007/s00415-021-10711-6
Delaby, C., Teunissen, C.E., Blennow, K., Alcolea, D., Arisi, I., Amar, E.B., ...Bigot-Corbel, E. (2021). Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimer's & Dementia, doi:10.1002/alz.12545
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I.E., ...Hernández, I. (2021). Common variants in Alzheimer's disease and risk stratification by polygenic risk scores. Nature Communications, 12 (1), doi:10.1038/s41467-021-22491-8
Keshavan, A., Wellington, H., Chen, Z., Khatun, A., Chapman, M., Hart, M., ...Buchanan, S.M. (2021). Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.. Alzheimer's and Dementia, 13 (1), doi:10.1002/dad2.12131
Parker, C., Foulkes, A., Slattery, C., Veale, T., Cash, D., Fox, N., ...Zhang, H. (2021). Disentangling axonal loss and demyelination using multi-modal imaging: application to young onset Alzheimer’s disease.
Lu, K., Nicholas, J.M., Pertzov, Y., Grogan, J., Husain, M., Pavisic, I.M., ...Keshavan, A. (2021). Dissociable effects of APOE ε4 and β-amyloid pathology on visual working memory. Nature Aging, doi:10.1038/s43587-021-00117-4
Thompson, A.G.B., Anastasiadis, P., Druyeh, R., Whitworth, I., Nayak, A., Nihat, A., ...Rohrer, J. (2021). Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases. Molecular Psychiatry, doi:10.1038/s41380-021-01045-w
Holstege, H., Hulsman, M., Charbonnier, C., Grenier-Boley, B., Quenez, O., Grozeva, D., ...Amin, N. (2021). Exome sequencing identifies rare damaging variants in the ATB8B4 and ABCA1 genes as novel risk factors for Alzheimer's disease.
Koriath, C.A.M., Kenny, J., Ryan, N.S., Rohrer, J.D., Schott, J.M., Houlden, H., ...Mead, S. (2021). Genetic testing in dementia — utility and clinical strategies. Nature Reviews Neurology, doi:10.1038/s41582-020-00416-1
Dercon, Q., Nicholas, J.M., James, S.N., Schott, J.M., Richards, M. (2021). Grip strength from midlife as an indicator of later-life brain health and cognition: evidence from a British birth cohort. BMC Geriatrics, 21 doi:10.1186/s12877-021-02411-7
Dercon, Q., Nicholas, J.M., James, S.-.N., Schott, J.M., Richards, M. (2021). Grip strength from midlife as an indicator of later-life brain health and cognition: evidence from a British birth cohort (vol 21, 475, 2021). BMC GERIATRICS, 21 (1), doi:10.1186/s12877-021-02445-x
Dercon, Q., Nicholas, J., James, S.-.N., Schott, J., Richards, M. (2021). GRIP STRENGTH FROM MIDLIFE AS AN INDICATOR OF LATER-LIFE COGNITION AND BRAIN HEALTH: EVIDENCE FROM A BRITISH BIRTH COHORT.
Lane, C.A., Barnes, J., Nicholas, J.M., Baker, J.W., Sudre, C.H., Cash, D.M., ...James, S.-.N. (2021). Investigating the relationship between BMI across adulthood and late life brain pathologies.. Alzheimer's Research and Therapy, 13 (1), 91. doi:10.1186/s13195-021-00830-7
Salzmann, A., James, S.N., Williams, D., Richards, M., Cadar, D., Schott, J., ...Garfield, V. (2021). Investigating the relationship between IGF-I, -II and IGFBP-3 concentrations and later-life cognition and brain volume. Journal of Clinical Endocrinology and Metabolism, doi:10.1210/clinem/dgab121
Belloy, M.E., Eger, S.J., Le Guen, Y., Napolioni, V., Deters, K.D., Yang, H.S., ...Wong, A. (2021). KL∗VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE∗4 carriers. Neurobiology of Aging, 101 123-129. doi:10.1016/j.neurobiolaging.2021.01.008
Veale, T., Malone, I.B., Poole, T., Parker, T.D., Slattery, C.F., Paterson, R.W., ...Zhang, H. (2021). Loss and dispersion of superficial white matter in Alzheimer's disease: a diffusion MRI study. Brain Communications, 3 (4), doi:10.1093/braincomms/fcab272
Buchanan, S.M., Richards, M., Schott, J.M., Schrag, A. (2021). Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological Associations. Movement Disorders, doi:10.1002/mds.28777
Graff-Radford, J., Yong, K.X.X., Apostolova, L.G., Bouwman, F.H., Carrillo, M., Dickerson, B.C., ...Murray, M.E. (2021). New insights into atypical Alzheimer's disease in the era of biomarkers.. Lancet Neurol, 20 (3), 222-234. doi:10.1016/S1474-4422(20)30440-3
Parker, C., Veale, T., Bocchetta, M., Slattery, C., Fox, N., Schott, J., ...Zhang, H. (2021). Not all voxels are created equal: reducing estimation bias in regional NODDI metrics using tissue-weighted mean.
Parker, C.S., Veale, T., Bocchetta, M., Slattery, C.F., Malone, I.B., Thomas, D.L., ...Zhang, H. (2021). Not all voxels are created equal: reducing estimation bias in regional NODDI metrics using tissue-weighted means. NeuroImage, doi:10.1016/j.neuroimage.2021.118749
Ball, H.A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D.J., Edwards, M.J., ...Isaacs, J.D. (2021). Reply: Functional cognitive disorder: dementia's blind spot. Brain, doi:10.1093/brain/awab305
Paterson, R.W., Benjamin, L.A., Mehta, P.R., Brown, R.L., Athauda, D., Ashton, N.J., ...Heslegrave, A.J. (2021). Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes. Brain Communications, 3 (3), doi:10.1093/braincomms/fcab099
Fatih, N., Chaturvedi, N., Lane, C.A., Parker, T.D., Lu, K., Cash, D.M., ...Barnes, J. (2021). Sex-related differences in whole brain volumes at age 70 in association with hyperglycemia during adult life. Neurobiology of Aging, doi:10.1016/j.neurobiolaging.2021.09.008
Pavisic, I.M., Lu, K., Keuss, S.E., James, S.-.N., Lane, C.A., Parker, T.D., ...Cash, D.M. (2021). Subjective cognitive complaints at age 70: associations with amyloid and mental health.. Journal of Neurology, Neurosurgery and Psychiatry, doi:10.1136/jnnp-2020-325620
Johnson, J.C.S., McWhirter, L., Hardy, C.J.D., Crutch, S.J., Marshall, C.R., Mummery, C.J., ...Weil, R.S. (2021). Suspecting dementia: canaries, chameleons and zebras.. Practical Neurology, doi:10.1136/practneurol-2021-003019
Pannee, J., Shaw, L.M., Korecka, M., Waligorska, T., Teunissen, C.E., Stoops, E., ...Keshavan, A. (2021). The global Alzheimer's Association round robin study on plasma amyloid β methods. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 13 (1), doi:10.1002/dad2.12242
Alawode, D.O.T., Heslegrave, A.J., Ashton, N.J., Karikari, T.K., Simrén, J., Montoliu-Gaya, L., ...Lantero-Rodriguez, J. (2021). Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease. Journal of Internal Medicine, doi:10.1111/joim.13332
Lu, K., Nicholas, J.M., Weston, P.S.J., Stout, J.C., O’Regan, A.M., James, S.N., ...Keuss, S.E. (2021). Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer’s disease. Brain Communications, doi:10.1093/braincomms/fcab003
Howard, R., Schott, J. (2021). When dementia is misdiagnosed.. International Journal of Geriatric Psychiatry, doi:10.1002/gps.5538

2020

Norsworthy, P.J., Thompson, A.G.B., Mok, T.H., Guntoro, F., Dabin, L.C., Nihat, A., ...Mead, S. (2020). A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis. Nature Communications, 11 (1), doi:10.1038/s41467-020-17655-x
de Pablo-Fernández, E., González-Herrero, B., Cerdán Santacruz, D., Rossor, M.N., Schott, J.M., Lashley, T., ...Warren, J.D. (2020). A Clinicopathologic Study of Movement Disorders in Frontotemporal Lobar Degeneration.. Mov Disord, doi:10.1002/mds.28356
C Dabin, L., Guntoro, F., Campbell, T., Bélicard, T., Smith, A.R., Smith, R.G., ...Sarkies, P. (2020). Altered DNA methylation profiles in blood from patients with sporadic Creutzfeldt-Jakob disease.. Acta Neuropathol, doi:10.1007/s00401-020-02224-9
Parker, T.D., Cash, D.M., Lane, C.A., Lu, K., Malone, I.B., Nicholas, J.M., ...Wong, A. (2020). Amyloid β influences the relationship between cortical thickness and vascular load. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 12 (1), doi:10.1002/dad2.12022
Mengoudi, K., Daniele, R., Yong, K., Primativo, S., Pavisic, I., Brotherhood, E., ...Alexander, D. (2020). Augmenting Dementia Cognitive Assessment with Instruction-less Eye-tracking Tests. IEEE Journal of Biomedical and Health Informatics, doi:10.1109/JBHI.2020.3004686
Gratwicke, J., Zrinzo, L., Kahan, J., Peters, A., Brechany, U., McNichol, A., ...Oswal, A. (2020). Bilateral Nucleus Basalis of Meynert Deep Brain Stimulation for dementia with Lewy bodies A Randomised Clinical Trial. Brain Stimulation, doi:10.1016/j.brs.2020.04.010
Zetterberg, H., Alawode, D., Keshavan, A., o'connor, A., Weston, P., Paterson, R., ...Schott, J. (2020). Blood Tests for Alzheimer Disease. Practical Neurology,
Banerjee, G., Ambler, G., Keshavan, A., Paterson, R.W., Foiani, M.S., Toombs, J., ...Groves, A.M. (2020). Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy. Journal of Alzheimer's Disease, doi:10.3233/JAD-191254
Woollacott, I.O.C., Nicholas, J.M., Heller, C., Foiani, M.S., Moore, K.M., Russell, L.L., ...Warren, J.D. (2020). Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.. Dement Geriatr Cogn Disord, 1-21. doi:10.1159/000506282
Keshavan, A., Wellington, H., Chen, Z., Khatun, A., Chapman, M., Hart, M., ...Buchanan, S. (2020). Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimer's and Dementia, doi:10.1002/dad2.12097
Graham, N.S.N., Jolly, A., Zimmerman, K., Bourke, N.J., Scott, G., Cole, J.H., ...Sharp, D.J. (2020). Diffuse axonal injury predicts neurodegeneration after moderate-severe traumatic brain injury. Brain, doi:10.1093/brain/awaa316
Ball, H.A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D.J., Edwards, M.J., ...Huntley, J. (2020). Functional cognitive disorder: dementia's blind spot. Brain, doi:10.1093/brain/awaa224
Williams, T., Houlden, H., Murphy, E., John, N., Fox, N.C., Schott, J.M., ...Lynch, D.S. (2020). How to diagnose difficult white matter disorders.. Pract Neurol, doi:10.1136/practneurol-2020-002530
Keuss, S., Parker, T., Lane, C., Hoskote, C., Shah, S., Cash, D., ...Wong, A. (2020). Incidental Findings on Brain Magnetic Resonance Imaging.
Lu, K., Nicholas, J.M., James, S., Lane, C.A., Parker, T.D., Keshavan, A., ...Cash, D.M. (2020). Increased variability in reaction time is associated with amyloid beta pathology at age 70. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 12 (1), doi:10.1002/dad2.12076
Salzmann, A., James, S.-.N., Williams, D., Richards, M., Cadar, D., Schott, J., ...Garfield, V. (2020). Investigating the relationship between IGF-I, -II and IGFBP-3 concentrations and later-life cognition and brain volume. .
Weston, P.S.J., Poole, T., Nicholas, J.M., Toussaint, N., Simpson, I.J.A., Modat, M., ...Schott, J.M. (2020). Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease. Alzheimer's Research & Therapy, 12 (1), 112. doi:10.1186/s13195-020-00679-2
Dunne, R.A., Aarsland, D., O'Brien, J.T., Ballard, C., Banerjee, S., Fox, N.C., ...Chan, D. (2020). Mild cognitive impairment: the Manchester consensus.. Age Ageing, doi:10.1093/ageing/afaa228
Buchanan, S.M., Parker, T.D., Lane, C.A., Keshavan, A., Keuss, S.E., Lu, K., ...Nicholas, J. (2020). Olfactory testing does not predict beta-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort. JOURNAL OF NEUROLOGY, doi:10.1007/s00415-020-10004-4
Street, R., Lu, K., Huckvale, M., Brotherhood, E., Pavisic, I., James, S., ...Lane, C.A. (2020). Performance on the graded naming test in a population-based sample of 72-year-olds: Associations with life-course predictors and β-amyloid pathology.
Obrocki, P., Khatun, A., Ness, D., Senkevich, K., Hanrieder, J., Capraro, F., ...Ashton, N.J. (2020). Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.. Alzheimer's Research & Therapy, 12 (1), 20. doi:10.1186/s13195-020-00586-6
Keshavan, A., Pannee, J., Karikari, T., Lantero Rodriguez, J., Ashton, N.J., Nicholas, J.M., ...Parker, T.D. (2020). Population-based blood screening for pre-clinical Alzheimer’s disease in a British birth cohort at age 70. Brain: a journal of neurology, doi:10.1093/brain/awaa403
Frisoni, G.B., Molinuevo, J.L., Altomare, D., Carrera, E., Barkhof, F., Berkhof, J., ...Nordberg, A. (2020). Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease-modifying therapies.. Alzheimers Dement, doi:10.1002/alz.12132
Paterson, R.W., Brown, R.L., Vivekanandam, V., Foulkes, A.J.M., Thom, M., Wiethoff, S., ...Morrow, J. (2020). Reply: Concentric demyelination pattern in COVID-19-associated acute haemorrhagic leukoencephalitis: a lurking catastrophe?. BRAIN, 143 doi:10.1093/brain/awaa377
Mason, S.A., Al Saikhan, L., Jones, S., Bale, G., James, S.-.N., Murray-Smith, H., ...Richards, M. (2020). Study Protocol - Insight 46 Cardiovascular: A Sub-study of the MRC National Survey of Health and Development.. Artery Res, 26 (3), 170-179. doi:10.2991/artres.k.200417.001
Bauermeister, S., Orton, C., Thompson, S., Barker, R.A., Bauermeister, J.R., Ben-Shlomo, Y., ...Calvin, C. (2020). The Dementias Platform UK (DPUK) Data Portal. European Journal of Epidemiology, doi:10.1007/s10654-020-00633-4
Paterson, R.W., Brown, R.L., Benjamin, L., Nortley, R., Wiethoff, S., Bharucha, T., ...Zambreanu, L. (2020). The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. BRAIN, 143 3104-3120. doi:10.1093/brain/awaa240
Fatih, N., James, S.N., Lane, C.A., Barnes, J., Parker, T.D., Keshavan, A., ...Richards, M. (2020). The relationship between mid-life hyperglycaemia and later-life brain outcomes: Focus on amyloidosis, whole brain volume and white matter disease.

2019

Altmann, A., Scelsi, M., Shoai, M., De Silva, E., Aksman, L., Cash, D., ...Schott, J. (2019). A comprehensive analysis of methods for assessing polygenic burden on Alzheimer’s disease pathology and risk beyond APOE. Brain Communications, doi:10.1093/braincomms/fcz047
Yong, K., Peters, A., Ocal, D., Cash, D., Bancroft, M., Kaski, D., ...Suarez Gonzalez, A. (2019). AM I THE RIGHT WAY UP?: INVESTIGATING BALANCE PROBLEMS IN POSTERIOR CORTICAL ATROPHY.
Frisoni, G.B., Barkhof, F., Altomare, D., Berkhof, J., Boccardi, M., Canzoneri, E., ...Garibotto, V. (2019). AMYPAD Diagnostic and Patient Management Study: Rationale and design. Alzheimer's and Dementia, doi:10.1016/j.jalz.2018.09.003
Koriath, C., Lashley, T., Taylor, W., Druyeh, R., Dimitriadis, A., Denning, N., ...Schott, J.M. (2019). ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 11 277-280. doi:10.1016/j.dadm.2019.01.010
Lane, C.A., Barnes, J., Nicholas, J.M., Sudre, C.H., Cash, D.M., Parker, T.D., ...Keshavan, A. (2019). Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study.. Lancet Neurol, doi:10.1016/S1474-4422(19)30228-5
Lane, C.A., Barnes, J., Nicholas, J.M., Sudre, C.H., Cash, D.M., Malone, I.B., ...Keuss, S.E. (2019). Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort.. JAMA Neurol, 1-9. doi:10.1001/jamaneurol.2019.3774
Kunkle, B.W., Grenier-Boley, B., Sims, R., Bis, J.C., Damotte, V., Naj, A.C., ...Amlie-Wolf, A. (2019). Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.. Nat Genet, doi:10.1038/s41588-019-0495-7
Zetterberg, H., Schott, J.M. (2019). Biomarkers for Alzheimer's disease beyond amyloid and tau.. Nat Med, 25 (2), 201-203. doi:10.1038/s41591-019-0348-z
Pan, X., Cunningham, E.L., Passmore, A.P., McGuinness, B., McAuley, D.F., Beverland, D., ...Zetterberg, H. (2019). Cerebrospinal Fluid Spermidine, Glutamine and Putrescine Predict Postoperative Delirium Following Elective Orthopaedic Surgery. Scientific Reports, 9 (1), 4191. doi:10.1038/s41598-019-40544-3
Lu, K., Nicholas, J.M., Collins, J.D., James, S.-.N., Parker, T.D., Lane, C.A., ...Murray-Smith, H. (2019). Cognition at age 70: Life course predictors and associations with brain pathologies. Neurology, doi:10.1212/WNL.0000000000008534
Clarke, M.T.M., Brinkmalm, A., Foiani, M.S., Woollacott, I.O.C., Heller, C., Heslegrave, A., ...Warren, J.D. (2019). CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia.. Alzheimers Res Ther, 11 (1), 105. doi:10.1186/s13195-019-0564-2
Bridel, C., Van Wieringen, W.N., Zetterberg, H., Tijms, B.M., Teunissen, C.E., Alvarez-Cermeño, J.C., ...Bartos, A. (2019). Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurology, doi:10.1001/jamaneurol.2019.1534
Tektonidis, T.G., Coe, S., Esser, P., Maddock, J., Buchanan, S., Mavrommati, F., ...Dawes, H. (2019). Diet quality in late midlife is associated with faster walking speed in later life in women, but not men: Findings from a prospective British birth cohort. British Journal of Nutrition, doi:10.1017/S0007114519003313
Garbarino, S., Lorenzi, M., Oxtoby, N.P., Vinke, E.J., Marinescu, R.V., Eshaghi, A., ...Barkhof, F. (2019). Differences in topological progression profile among neurodegenerative diseases from imaging data.. Elife, 8 doi:10.7554/eLife.49298
James, S.N., Lane, C.A., Parker, T.D., Lu, K., Keshavan, A., Buchanan, S.M., ...Nicholas, J.M. (2019). DIVERGENT ASSOCIATIONS BETWEEN LIFE COURSE COGNITIVE TRAJECTORIES AND BRAIN PATHOLOGIES: FINDINGS FROM THE 1946 BRITISH BIRTH COHORT.
Wittenberg, R., Knapp, M., Karagiannidou, M., Dickson, J., Schott, J. (2019). Economic impacts of introducing diagnostics for mild cognitive impairment Alzheimer's disease patients. Alzheimer's and Dementia: Translational Research and Clinical Interventions, 5 382-387. doi:10.1016/j.trci.2019.06.001
Arber, C., Toombs, J., Lovejoy, C., Ryan, N.S., Paterson, R.W., Willumsen, N., ...Heslegrave, A. (2019). Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta. Molecular Psychiatry, doi:10.1038/s41380-019-0410-8
Kunkle, B.W., Grenier-Boley, B., Sims, R., Bis, J.C., Damotte, V., Naj, A.C., ...Amlie-Wolf, A. (2019). Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.. Nat Genet, 51 (3), 414-430. doi:10.1038/s41588-019-0358-2
Parker, T.D., Cash, D.M., Lane, C.A.S., Lu, K., Malone, I.B., Nicholas, J.M., ...Wong, A. (2019). Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946.. PLoS One, 14 (10), e0224030. doi:10.1371/journal.pone.0224030
Keuss, S.E., Parker, T.D., Lane, C.A., Hoskote, C., Shah, S., Cash, D.M., ...Wong, A. (2019). Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohort. BMJ Open, 9 (7), e029502. doi:10.1136/bmjopen-2019-029502
Chen, Z., Mengel, D., Keshavan, A., Rissman, R.A., Billinton, A., Perkinton, M., ...Johnson, K. (2019). Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.. Alzheimer's and Dementia, doi:10.1016/j.jalz.2018.09.010
Weston, P.S.J., Poole, T., O'Connor, A., Heslegrave, A., Ryan, N.S., Liang, Y., ...Schott, J.M. (2019). Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.. Alzheimers Res Ther, 11 (1), 19. doi:10.1186/s13195-019-0472-5
Firth, N.C., Primativo, S., Marinescu, R.-.V., Shakespeare, T.J., Suarez-Gonzalez, A., Lehmann, M., ...Paterson, R.W. (2019). Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy.. Brain, doi:10.1093/brain/awz136
Keuss, S.E., Bowen, J., Schott, J.M. (2019). Looking beyond the eyes: visual impairment in posterior cortical atrophy. The Lancet, 394 (10203), 1055. doi:10.1016/S0140-6736(19)31818-5
Altmann, A., Scelsi, M.A., Shoai, M., de Silva, E., Cash, D.M., Hardy, J., Schott, J.M. (2019). P4-490: ALZHEIMER'S DISEASE POLYGENIC BURDEN BEYOND APOE ACTS STRONGER ON TAU THAN ON AMYLOID.
Ocal, D., Peters, A., Cash, D., Bancroft, M., Kaski, D., Veale, T., ...Collins, J. (2019). Perception of verticality in typical Alzheimer's disease and posterior cortical atrophy: neuroanatomical and neuropsychological correlates.
Schott, J.M., Crutch, S.J. (2019). Posterior Cortical Atrophy.. Continuum (Minneap Minn), 25 (1), 52-75. doi:10.1212/CON.0000000000000696
Canas, L.S., Sudre, C.H., De Vita, E., Nihat, A., Mok, T.H., Slattery, C.F., ...Cardoso, M.J. (2019). Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process. NeuroImage: Clinical, 102051. doi:10.1016/j.nicl.2019.102051
Parker, T., Cash, D.M., Lane, C., Lu, K., Malone, I.B., Nicholas, J.M., ...Wong, A. (2019). Pure tone audiometry and cerebral pathology in healthy older adults. Journal of Neurology, Neurosurgery & Psychiatry, doi:10.1136/jnnp-2019-321897
Buchanan, S.M., Parker, T.D., Lane, C.A., Keshavan, A., Keuss, S.E., Schrag, A.E., ...Schott, J.M. (2019). RELATIONSHIPS BETWEEN WALKING SPEED, COGNITION & BRAIN PATHOLOGIES: AN IMAGING STUDY OF THE 1946 BIRTH COHORT.
den Haan, J., Csinscik, L., Parker, T., Paterson, R.W., Slattery, C.F., Foulkes, A., ...Peto, T. (2019). Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.. Alzheimers Res Ther, 11 (1), 62. doi:10.1186/s13195-019-0516-x
Foiani, M.S., Cicognola, C., Ermann, N., Woollacott, I.O.C., Heller, C., Heslegrave, A.J., ...Kornhuber, J. (2019). Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.. J Neurol Neurosurg Psychiatry, doi:10.1136/jnnp-2018-319266
Paterson, R.W., Gabelle, A., Lucey, B.P., Barthélemy, N.R., Leckey, C.A., Hirtz, C., ...West, T. (2019). SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.. Nat Rev Neurol, doi:10.1038/s41582-019-0222-0
Sani, T.P., Bond, R.L., Marshall, C.R., Hardy, C.J.D., Russell, L.L., Moore, K.M., ...Wendi, I.P. (2019). Sleep symptoms in syndromes of frontotemporal dementia and Alzheimer's disease: A proof-of-principle behavioural study. eNeurologicalSci, 17 doi:10.1016/j.ensci.2019.100212
Buchanan, S., Lane, C., Lu, K., Parker, T., James, S., Keshavan, A., ...Cash, D. (2019). The cognitive profile associated with mild parkinsonian signs in a British Birth Cohort at age 69-71.
Slattery, C.F., Agustus, J.L., Paterson, R.W., McCallion, O., Foulkes, A.J.M., Macpherson, K., ...Jaisin, K. (2019). The functional neuroanatomy of musical memory in Alzheimer's disease. Cortex, doi:10.1016/j.cortex.2019.02.003
Weaver, N.A., Zhao, L., Biesbroek, J.M., Kuijf, H.J., Aben, H.P., Bae, H.J., ...Dichgans, M. (2019). The Meta VCI Map consortium for meta-analyses on strategic lesion locations for vascular cognitive impairment using lesion-symptom mapping: Design and multicenter pilot study. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 11 310-326. doi:10.1016/j.dadm.2019.02.007
Schott, J.M., Aisen, P.S., Cummings, J.L., Howard, R.J., Fox, N.C. (2019). Unsuccessful trials of therapies for Alzheimer's disease. The Lancet, 393 (10166), 29. doi:10.1016/S0140-6736(18)31896-8
Hansson, K., Dahlén, R., Hansson, O., Pernevik, E., Paterson, R., Schott, J.M., ...Gobom, J. (2019). Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease. Clinical Mass Spectrometry, doi:10.1016/j.clinms.2019.07.002

2018

Weston, P.S.J., Poole, T., Ryan, N.S., Nair, A., Liang, Y., Macpherson, K., ...Pemberton, H. (2018). Accelerated long-term forgetting in presymptomatic Autosomal Dominant Alzheimer’s disease: A cross-sectional study. Lancet Neurology, doi:10.1016/S1474-4422(17)30434-9
Buchanan, S.M., Schott, J.M. (2018). Aide-mémoires in semantic dementia. Practical Neurology, doi:10.1136/practneurol-2018-001973
Lane, C.A., Hardy, J., Schott, J.M. (2018). Alzheimer's disease. European Journal of Neurology, doi:10.1111/ene.13439
Toombs, J., Foiani, M.S., Wellington, H., Paterson, R.W., Arber, C., Heslegrave, A., ...Zetterberg, H. (2018). Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 10 311-321. doi:10.1016/j.dadm.2018.02.005
Anttila, V., Bulik-Sullivan, B., Finucane, H.K., Walters, R.K., Bras, J., Duncan, L., ...Malik, R. (2018). Analysis of shared heritability in common disorders of the brain. Science (New York, N.Y.), 360 (6395), doi:10.1126/science.aap8757
Skillbäck, T., Lautner, R., Mattsson, N., Schott, J.M., Nägga, K., Kilander, L., ...Blennow, K. (2018). Apolipoprotein E genotypes and longevity across dementia disorders.. Alzheimer's and Dementia, doi:10.1016/j.jalz.2018.02.003
Paterson, R.W., Slattery, C.F., Poole, T., Nicholas, J.M., Magdalinou, N.K., Toombs, J., ...Foiani, M.S. (2018). Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.. Alzheimer's research & therapy, 10 (1), 32. doi:10.1186/s13195-018-0361-3
Woollacott, I.O.C., Nicholas, J.M., Heslegrave, A., Heller, C., Foiani, M.S., Dick, K.M., ...Fox, N.C. (2018). Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Alzheimer's Research and Therapy, 10 (1), doi:10.1186/s13195-018-0405-8
Soane, T., Schott, J.M., Stone, J., Smith, C., Davenport, R.J. (2018). Clinicopathological case: Progressive somnolence and dementia in an accountant: When the shine rubs off the gold standard. Practical Neurology, doi:10.1136/practneurol-2018-001989
Georgiadis, K., Young, A.L., Hütel, M., Razi, A., Semedo, C., Schott, J., ...Modat, M. (2018). Computational modelling of pathogenic protein behaviour-governing mechanisms in the brain.
Parker, T.D., Slattery, C.F., Zhang, J., Nicholas, J.M., Paterson, R.W., Foulkes, A.J.M., ...Cash, D.M. (2018). Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging. Human Brain Mapping, doi:10.1002/hbm.24056
Cunningham, E.L., McGuinness, B., McAuley, D.F., Toombs, J., Mawhinney, T., O'Brien, S., ...Zetterberg, H. (2018). CSF Beta-amyloid 1-42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort Study.. Annals of surgery, doi:10.1097/sla.0000000000002684
Wellington, H., Paterson, R., Suarez-Gonzalez, A., Poole, T., Frost, C., Sjobom, U., ...Portelius, E. (2018). CSF Neurogranin or Tau distinguish typical and atypical Alzheimer Disease. Annals of Clinical and Translational Neurology, doi:10.1002/acn3.518
Oxtoby, N., Young, A., Cash, D., Benzinger, T., Fagan, A., Morris, J., ...Alexander, D. (2018). Data-driven models of dominantly-inherited Alzheimer’s disease progression. .
Parker, T.D., Slattery, C.F., Yong, K.X.X., Nicholas, J.M., Paterson, R.W., Foulkes, A.J.M., ...Crutch, S.J. (2018). Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease. NeuroImage: Clinical, doi:10.1016/j.nicl.2018.101632
Schott, J.M. (2018). Frontal lobe dementias.
Scelsi, M.A., Khan, R.R., Lorenzi, M., Christopher, L., Greicius, M.D., Schott, J., ...Altmann, A. (2018). Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci. Brain, doi:10.1093/brain/awy141
Daskalakis, M., Brocks, D., Schmidt, C.R., Goyal, A., Li, D., Laudato, S., ...Assenov, Y. (2018). In vitro models for epigenetic therapy: gene reactivation via cryptic transcription start sites of endogenous retroviral elements.
Lashley, T., Schott, J.M., Weston, P., Murray, C.E., Wellington, H., Keshavan, A., ...Rohrer, J.D. (2018). Molecular biomarkers of Alzheimer's disease: progress and prospects.. Disease models & mechanisms, 11 (5), doi:10.1242/dmm.031781
Marshall, C.R., Hardy, C.J.D., Russell, L.L., Clark, C.N., Bond, R.L., Dick, K.M., ...Rohrer, J.D. (2018). Motor signatures of emotional reactivity in frontotemporal dementia. SCIENTIFIC REPORTS, 8 doi:10.1038/s41598-018-19528-2
Parker, T.D., Schott, J. (2018). Navigating genetic influences on the topography of Alzheimer’s disease. Biological Psychiatry, doi:10.1016/j.biopsych.2018.07.012
Yong, K.X.X., Mccarthy, I.D., Poole, T., Suzuki, T., Yang, B., Carton, A.M., ...Langham, J. (2018). Navigational cue effects in Alzheimer's disease and posterior cortical atrophy. Annals of Clinical and Translational Neurology, doi:10.1002/acn3.566
Foiani, M.S., Woollacott, I.O., Heller, C., Bocchetta, M., Heslegrave, A., Dick, K.M., ...Schott, J.M. (2018). Plasma tau is increased in frontotemporal dementia.. Journal of Neurology, Neurosurgery and Psychiatry, doi:10.1136/jnnp-2017-317260
Lynch, D.S., Wade, C., Paiva, A.R.B.D., John, N., Kinsella, J.A., Merwick, Á., ...Schott, J.M. (2018). Practical approach to the diagnosis of adult-onset leukodystrophies: An updated guide in the genomic era. Journal of Neurology, Neurosurgery and Psychiatry, doi:10.1136/jnnp-2018-319481
Koriath, C., Kenny, J., ADAMSON, G., Druyeh, R., Taylor, W., Quinn, L., ...Mead, S. (2018). Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Molecular Psychiatry, doi:10.1038/s41380-018-0224-0
Bergeron, D., Gorno-Tempini, M.L., Rabinovici, G.D., Santos-Santos, M.A., Seeley, W., Miller, B.L., ...van Berckel, B.N.M. (2018). Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia.. Annals of Neurology, doi:10.1002/ana.25333
Marshall, C.R., Hardy, C.J.D., Volkmer, A., Russell, L.L., Bond, R.L., Fletcher, P.D., ...Rossor, M.N. (2018). Primary progressive aphasia: a clinical approach.. Journal of neurology, doi:10.1007/s00415-018-8762-6
Scott, C.J., Jiao, J., Melbourne, A., Burgos, N., Cash, D.M., De Vita, E., ...Weston, P.S. (2018). Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL-MRI: proof of concept. Journal of Cerebral Blood Flow and Metabolism, 271678X18797343. doi:10.1177/0271678X18797343
Scott, C.J., Jiao, J., Cardoso, M.J., Kläser, K., Melbourne, A., Markiewicz, P.J., ...Ourselin, S. (2018). Short acquisition time PET/MR pharmacokinetic modelling using CNNs.
Keshavan, A., Heslegrave, A., Zetterberg, H., Schott, J.M. (2018). Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 10 448-451. doi:10.1016/j.dadm.2018.06.001
Lorenzi, M., Altmann, A., Gutman, B., Wray, S., Arber, C., Hibar, D., ...Thompson, P. (2018). Susceptibility of brain atrophy to TRIB3 in Alzheimer’s disease: evidence from functional prioritization in imaging-genetics. Proceedings of the National Academy of Sciences, doi:10.1073/pnas.1706100115
Young, A., Marinescu, R., Oxtoby, N., Bocchetta, M., Yong, K., Firth, N., ...Cardoso, J. (2018). Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference. Nature Commun, 9 4273. doi:10.1038/s41467-018-05892-0
Kinsella, J.A., Irani, S.R., Hollingsworth, R., O'Shaughnessy, D., Kane, P., Foster, M., ...Lunn, M.P. (2018). Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience. JRSM Open, 9 (9), 2054270418793021. doi:10.1177/2054270418793021
James, S.-.N., Lane, C.A., Parker, T.D., Lu, K., Collins, J.D., Murray-Smith, H., ...Buchanan, S. (2018). Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46.. BMC Research Notes, 11 (1), 885. doi:10.1186/s13104-018-3995-0

2017

Manning, E.N., Leung, K.K., Nicholas, J., Malone, I.B., Cardoso, M.J., Schott, J., ...Barnes, J. (2017). A Comparison of Accelerated and Non-accelerated MRI Scans for Brain Volume and Boundary Shift Integral Measures of Volume Change: Evidence from the ADNI Dataset. Neuroinformatics, doi:10.1007/s12021-017-9326-0
Slattery, C.F., Zhang, J., Paterson, R.W., Foulkes, A.J.M., Carton, A., Macpherson, K., ...Toussaint, N. (2017). ApoE influences regional white-matter axonal density loss in Alzheimer's disease. Neurobiology of Aging, 57 8-17. doi:10.1016/j.neurobiolaging.2017.04.021
Keshavan, A., Heslegrave, A., Zetterberg, H., Schott, J.M. (2017). Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress. MOLECULAR DIAGNOSIS & THERAPY, 21 (1), 13-22. doi:10.1007/s40291-016-0241-0
Zetterberg, H., Rohrer, J.D., Schott, J.M. (2017). Cerebrospinal fluid in the dementias.. Handbook of Clinical Neurology, 146 85-97. doi:10.1016/b978-0-12-804279-3.00006-x
Lynch, D.S., Rodrigues Brandão de Paiva, A., Zhang, W.J., Bugiardini, E., Freua, F., Tavares Lucato, L., ...Merwick, A. (2017). Clinical and genetic characterization of leukoencephalopathies in adults.. Brain : a journal of neurology, doi:10.1093/brain/awx045
Schrag, A., Siddiqui, U.F., Anastasiou, Z., Weintraub, D., Schott, J.M. (2017). Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study. Lancet Neurol, 16 (1), 66-75. doi:10.1016/S1474-4422(16)30328-3
Schrag, A., Weintraub, D., Schott, J.M. (2017). Cognitive decline before diagnosis of Parkinson's disease Reply. LANCET NEUROLOGY, 16 (4), 262.
Crutch, S.J., Schott, J.M., Rabinovici, G.D., Murray, M., Snowden, J.S., van der Flier, W.M., ...Bak, T.H. (2017). Consensus classification of posterior cortical atrophy.. Alzheimer's & Dementia, doi:10.1016/j.jalz.2017.01.014
Wojtowicz, A., Schott, J.M., Larner, A.J. (2017). CSF biomarkers and the diagnosis of variant forms of Alzheimer's disease. Progress in Neurology and Psychiatry, 21 (2), 13-15. doi:10.1002/pnp.465
Weil, R.S., Lashley, T.L., Bras, J., Schrag, A.E., Schott, J.M. (2017). Current concepts and controversies in the pathogenesis of Parkinson’s disease dementia and Dementia with Lewy Bodies. F1000Research, 6 1604. doi:10.12688/f1000research.11725.1
Oxtoby, N.P., Garbarino, S., Firth, N.C., Warren, J.D., Schott, J.M., Alexander, D.C. (2017). Data-Driven Sequence of Changes to Anatomical Brain Connectivity in Sporadic Alzheimer's Disease. FRONTIERS IN NEUROLOGY, 8 doi:10.3389/fneur.2017.00580
Toombs, J., Foiani, M.S., Paterson, R.W., Heslegrave, A., Wray, S., Schott, J.M., ...Zetterberg, H. (2017). Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.. Journal of Alzheimer's Disease, doi:10.3233/JAD-161126
Daskalakis, M., Brocks, D., Schmidt, C., Li, D., Bo, Z., Laudato, S., ...Assenov, Y. (2017). Epigenetic drug treatment globally induces cryptic transcription start sites encoded in long terminal repeats.
Daskalakis, M., Brocks, D., Schmidt, C.R., Li, D., Li, J., Jang, H.S., ...Schott, J. (2017). EPIGENETIC DRUG TREATMENT GLOBALLY INDUCES CRYPTIC TRANSCRIPTION START SITES ENCODED IN LONG TERMINAL REPEATS (LTRS).
Pavisic, I.M., Firth, N.F., Parsons, S., Martinez Rego, D., Shakespeare, T.J., Yong, K.X.X., ...Macpherson, K. (2017). Eyetracking Metrics in Young Onset Alzheimer’s Disease: A Window into Cognitive Visual Functions. Frontiers in Neurology,
Ehrhardt, M.J., Markiewicz, P., Chambolle, A., Richtárik, P., Schott, J., Schönlieb, C.B. (2017). Faster PET reconstruction with a stochastic primal-dual hybrid gradient method.
Schott, J.M. (2017). Imaging the ageing brain: identifying early disease or opening Pandora's box?. LANCET NEUROLOGY, 16 (6), 411-413. doi:10.1016/S1474-4422(17)30116-3
Marshall, C.R., Hardy, C.J.D., Russell, L.L., Clark, C.N., Dick, K.M., Brotherhood, E.V., ...Rohrer, J.D. (2017). Impaired Interoceptive Accuracy in Semantic Variant Primary Progressive Aphasia. Frontiers in neurology, 8 610. doi:10.3389/fneur.2017.00610
Drews, A., De, S., Flagmeier, P., Wirthensohn, D.C., Chen, W.-.H., Whiten, D.R., ...Slattery, C.F. (2017). Inhibiting the Ca2+ Influx Induced by Human CSF. CELL REPORTS, 21 (11), 3310-3316. doi:10.1016/j.celrep.2017.11.057
Zhang, J., Slattery, C., Paterson, R., Foulkes, A., Mancini, L., Thomas, D., ...Thornton, J. (2017). Longitudinal Progression of White Matter Deficits in Young Onset Alzheimer's Disease and Its Syndromic Variants Using NODDI.
Markiewicz, P.J., Ehrhardt, M., Erlandsson, K., Noonan, P.J., Barnes, A., Schott, J.M., ...Ourselin, S. (2017). NiftyPET: A high-throughput software platform for high quantitative accuracy and precision PET imaging and analysis. Neuroinformatics, doi:10.1007/s12021-017-9352-y
Harper, L., Bouwman, F., Burton, E.J., Barkhof, F., Scheltens, P., O'Brien, J.T., ...Schott, J.M. (2017). Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis.. Journal of Neurology, Neurosurgery, and Psychiatry, doi:10.1136/jnnp-2016-314978
Lakshmanan, R., Adams, M.E., Lynch, D.S., Kinsella, J.A., Phadke, R., Schott, J.M., ...Houlden, H. (2017). Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy.. Neurology. Genetics, 3 (2), e135. doi:10.1212/nxg.0000000000000135
Weston, P.S.J., Poole, T., Ryan, N.S., Nair, A., Liang, Y., Macpherson, K., ...Pemberton, H. (2017). Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.. Neurology, doi:10.1212/wnl.0000000000004667
Scott, C.J., Jiao, J., Cardoso, M.J., Melbourne, A., De Vita, E., Thomas, D.L., ...Hutton, B.F. (2017). Short acquisition time PET quantification using MRI-based pharmacokinetic parameter synthesis.
Frisoni, G.B., Boccardi, M., Barkhof, F., Blennow, K., Cappa, S., Chiotis, K., ...Gietl, A. (2017). Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.. The Lancet. Neurology, 16 (8), 661-676. doi:10.1016/s1474-4422(17)30159-x
Lane, C.A., Parker, T.D., Cash, D.M., Macpherson, K., Donnachie, E., Murray-Smith, H., ...Bras, J. (2017). Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development. BMC Neurology, 17 (1), doi:10.1186/s12883-017-0846-x
Schott, J.M. (2017). The neurology of ageing: What is normal?. Practical Neurology, 17 (3), 172-182. doi:10.1136/practneurol-2016-001566
Olsson, B., Schott, J.M., Blennow, K., Zetterberg, H. (2017). The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials.. Expert review of neurotherapeutics, 17 (8), 767-775. doi:10.1080/14737175.2017.1341311

2016

Heywood, W.E., Baud, A., Bliss, E., Sirka, E., Schott, J.M., Zetterberg, H., ...Mills, K. (2016). A high throughput, multiplexed and targeted proteomic CSF assay to quantify neurodegenerative biomarkers and apolipoprotein E isoforms status. Journal of Visualized Experiments, 2016 (116), doi:10.3791/54541
Jun, G., Ibrahim-Verbaas, C.A., Vronskaya, M., Lambert, J.-.C., Chung, J., Naj, A.C., ...Bellenguez, C. (2016). A novel Alzheimer disease locus located near the gene encoding tau protein. MOLECULAR PSYCHIATRY, 21 (1), 108-117. doi:10.1038/mp.2015.23
Lehmann, M., Melbourne, A., Dickson, J.C., Ahmed, R.M., Modat, M., Cardoso, M.J., ...Warren, J.D. (2016). A novel use of arterial spin labelling MRI to demonstrate focal hypoperfusion in individuals with posterior cortical atrophy: A multimodal imaging study. Journal of Neurology, Neurosurgery and Psychiatry, 87 (9), 1032-1034. doi:10.1136/jnnp-2015-312782
Fletcher, P.D., Nicholas, J.M., Downey, L.E., Golden, H.L., Clark, C.N., Pires, C., ...Rohrer, J.D. (2016). A physiological signature of sound meaning in dementia. CORTEX, 77 13-23. doi:10.1016/j.cortex.2016.01.007
Paterson, R.W., Heywood, W.E., Heslegrave, A.J., Magdalinou, N.K., Andreasson, U., Sirka, E., ...Svensson, J. (2016). A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.. Transl Psychiatry, 6 (11), e952. doi:10.1038/tp.2016.194
Clark, C.N., Nicholas, J.M., Gordon, E., Golden, H.L., Cohen, M.H., Woodward, F.J., ...Schott, J.M. (2016). Altered sense of humor in dementia. Journal of Alzheimer's Disease, 49 (1), 111-119. doi:10.3233/JAD-150413
Scott, C.J., Jiao, J., Melbourne, A., Schott, J.M., Hutton, B.F., Ourselin, S. (2016). ASL-incorporated pharmacokinetic modelling of PET data with reduced acquisition time: Application to amyloid imaging.
Scott, C.J., Jiao, J., Melbourne, A., Schott, J.M., Hutton, B.F., Ourselin, S. (2016). ASL-incorporated Pharmacokinetic Modelling of PET Data With Reduced Acquisition Time: Application to Amyloid Imaging. In Lecture Notes in Computer Science. (pp. 406-413). Springer International Publishing.
Schott, J.M., Zetterberg, H. (2016). Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease. In I.n.g.e.l.s.s.o.n., Lannfelt, L. (Eds.), Immunotherapy and Biomarkers in Neurodegenerative Disorders. .
Sander, K., Lashley, T., Gami, P., Gendron, T., Lythgoe, M.F., Rohrer, J., ...Arstad, E. (2016). Characterisation of tau PET tracer [18F]AV-1451 binding to post-mortem tissue in Alzheimer's disease, primary tauopathies and other dementias. Alzheimer's & Dementia, doi:10.1016/j.jalz.2016.01.003
Rossor, M., Collinge, J., Fox, N., Mead, S., Mummery, C., Rohrer, J., ...Warren, J. (2016). Dementia and Cognitive Impairment. In Neurology: A Queen Square Textbook: Second Edition. (pp. 289-336). .
Weston, P.S., Paterson, R.W., Dickson, J., Barnes, A., Bomanji, J.B., Kayani, I., ...Rossor, M.N. (2016). Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?. Journal of Alzheimer's disease : JAD, doi:10.3233/JAD-160302
Jiao, J., Bousse, A., Thielemans, K., Burgos, N., Weston, P., Markiewicz, P., ...Hutton, B. (2016). Direct Parametric Reconstruction with Joint Motion Estimation/Correction for Dynamic Brain PET Data.. IEEE Trans Med Imaging, doi:10.1109/TMI.2016.2594150
Brocks, D., Schmidt, C.R., Daskalakis, M., Li, D., Li, J., Jang, H.S., ...Bierhoff, H. (2016). DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats.
Suarez-Gonzalez, A., Lehmann, M., Shakespeare, T.J., Yong, K.X.X., Paterson, R.W., Slattery, C.F., ...Roldan-Lora, F. (2016). Effect of age at onset on cortical thickness and cognition in posterior cortical atrophy. NEUROBIOLOGY OF AGING, 44 108-113. doi:10.1016/j.neurobiolaging.2016.04.012
Daskalakis, M., Brocks, D., Schmidt, C., Li, D., Li, J., Jang, H.S., ...Bierhoff, H. (2016). Epigenetic Drug Treatment Globally Induces Cryptic Transcription Start Sites Encoded in Long Terminal Repeats.
Clark, C., Golden, H., McCallion, O., Nicholas, J., Cohen, M., Mummery, C., ...Warren, J. (2016). EXPECTATION AND REWARD IN DEMENTIA: THE CASE OF MUSIC.
Clark, C., Golden, H., McCallion, O., Nicholas, J., Cohen, M., Slattery, C., ...Schott, J. (2016). Expectation and reward in frontotemporal dementia: the case of music.
Golden, H.L., Agustus, J.L., Nicholas, J.M., Schott, J.M., Crutch, S.J., Mancini, L., Warren, J.D. (2016). Functional neuroanatomy of spatial sound processing in Alzheimer's disease. Neurobiology of Aging, 39 154-164. doi:10.1016/j.neurobiolaging.2015.12.006
Schott, J.M., Crutch, S.J., Carrasquillo, M.M., Uphill, J., Shakespeare, T.J., Ryan, N.S., ...Graff-Radford, N.R. (2016). Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association, 12 (8), 862-871. doi:10.1016/j.jalz.2016.01.010
Heywood, W.E., Galimberti, D., Bliss, E., Sirka, E., Paterson, R.W., Magdalinou, N.K., ...Fenoglio, C. (2016). Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay (vol 10, 64, 2015). MOLECULAR NEURODEGENERATION, 11 doi:10.1186/s13024-016-0086-3
Heslegrave, A., Heywood, W., Paterson, R., Magdalinou, N., Svensson, J., Johansson, P., ...Schott, J. (2016). Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. MOLECULAR NEURODEGENERATION, 11 doi:10.1186/s13024-016-0071-x
Wellington, H., Paterson, R.W., Portelius, E., Tornqvist, U., Magdalinou, N., Fox, N.C., ...Zetterberg, H. (2016). Increased CSF neurogranin concentration is specific to Alzheimer disease. NEUROLOGY, 86 (9), 829-835. doi:10.1212/WNL.0000000000002423
Schott, J.M., Fox, N.C. (2016). Inflammatory changes in very early Alzheimer's disease: friend, foe, or don't know?. Brain, 139 (3), 647-650. doi:10.1093/brain/awv405
Markiewicz, P., Schott, J., Atkinson, D., Arridge, S., Hutton, B., Ourselin, S. (2016). Infrastructure for efficient multi-component uncertainty estimation of SUVR values in amyloid PET imaging.
Weston, P., Liang, Y., Henley, S., Nicholas, J., Ryan, N., Schott, J., ...Fox, N. (2016). LONG-TERM FORGETTING IN PRECLINICAL FAMILIAL ALZHEIMER'S DISEASE.
Harper, L., Fumagalli, G.G., Barkhof, F., Scheltens, P., O'Brien, J.T., Bouwman, F., ...Ridgway, G.R. (2016). MRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases. BRAIN, 139 1211-1225. doi:10.1093/brain/aww005
Lorenzi, M., Simpson, I.J., Mendelson, A.F., Vos, S.B., Cardoso, M.J., Modat, M., ...Ourselin, S. (2016). Multimodal Image Analysis in Alzheimer's Disease via Statistical Modelling of Non-local Intensity Correlations. SCIENTIFIC REPORTS, 6 doi:10.1038/srep22161
Golden, H.L., Clark, C.N., Nicholas, J.M., Cohen, M.H., Slattery, C.F., Paterson, R.W., ...Crutch, S.J. (2016). Music Perception in Dementia.. Journal of Alzheimer's Disease, doi:10.3233/JAD-160359
Zhang, J., Slattery, C., Paterson, R., Foulkes, A., Mancini, L., Thomas, D.L., ...Thornton, J. (2016). Neurite Orientation Dispersion and Density Imaging (NODDI) in Young Onset Alzheimer's Disease and Its Syndromic Variants.
Schott, J.M. (2016). Oxford Textbook of Cognitive Neurology and Dementia. Oxford University Press.
Revesz, T., Lashley, T., Holton, J. (2016). Pathology of degenerative dementias. In Husain, M., Schott, J. (Eds.), Oxford Textbook of Cognitive Neurology and Dementia. Oxford University Press.
Weston, P.S., Nicholas, J.M., Lehmann, M., Ryan, N.S., Liang, Y., Macpherson, K., ...Ourselin, S. (2016). Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.. Neurology, doi:10.1212/WNL.0000000000003322
Koriath, C., Adamson, G., Druyeh, R., Kenny, J., Rossor, M., Schott, J., ...Collinge, J. (2016). Probing FTD genetics with a next-generation sequencing gene panel.
Koriath, C., Adamson, G., Druyeh, R., Kenny, J., Rossor, M., Schott, J., ...Mead, S. (2016). PROBING FTD GENETICS WITH NEXT-GENERATION SEQUENCING.
Clark, C., Agustus, J., Nicholas, J., Hardy, C., Mummery, C., Schott, J., ...Warren, J. (2016). Processing of auditory conflict in frontotemporal dementia.
Markiewicz, P.J., Thielemans, K., Schott, J.M., Atkinson, D., Arridge, S., Hutton, B., Ourselin, S. (2016). Rapid processing of PET list-mode data for efficient uncertainty estimation and data analysis. Physics in Medicine and Biology, 61 (13), doi:10.1088/0031-9155/61/13/N322
Mattsson, N., Schott, J.M., Hardy, J., Turner, M.R., Zetterberg, H. (2016). Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.. Journal of neurology, neurosurgery, and psychiatry, 87 (9), 1000-1004. doi:10.1136/jnnp-2015-311321
Rohrer, J.D., Woollacott, I.O.C., Dick, K.M., Brotherhood, E., Gordon, E., Fellows, A., ...Ourselin, S. (2016). Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. NEUROLOGY, 87 (13), 1329-1336. doi:10.1212/WNL.0000000000003154
Woollacott, I., Rohrer, J., Dick, K., Brotherhood, E., Gordon, E., Fellows, A., ...Ourselin, S. (2016). Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
Paterson, R.W., Abdi, Z., Haines, A., Schott, J.M. (2016). Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy. CLINICAL NEUROLOGY AND NEUROSURGERY, 144 64-66. doi:10.1016/j.clineuro.2016.02.036
Schott, J.M., Rossor, M.N. (2016). The palmomental reflex: Stop scratching around!. Practical Neurology, 16 (6), 500-501. doi:10.1136/practneurol-2016-001509
Schott, J.M. (2016). The parietal lobes.

2015

Magdalinou, N.K., Paterson, R., Schott, J., Fox, N., Mummery, C., Blennow, K., ...Warner, T. (2015). A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. Journal of Neurology, Neurosurgery and Psychiatry, doi:10.1136/jnnp-2014-309562
Young, A.L., Oxtoby, N.P., Ourselin, S., Schott, J.M., Alexander, D.C. (2015). A simulation system for biomarker evolution in neurodegenerative disease. Medical Image Analysis, 26 (1), 47-56. doi:10.1016/j.media.2015.07.004
Fletcher, P., Rohrer, J., Schott, J., Rossor, M., Warren, J. (2015). ABNORMAL PAIN AND TEMPERATURE PROCESSING IN DEMENTIA.
Fletcher, P., Schott, J., Rossor, M., Warren, J. (2015). ABNORMAL SOUND AND MUSIC REWARD PROCESSING IN DEMENTIA: A BEHAVIOURAL AND NEUROANATOMICAL ANALYSIS.
Shakespeare, T., Kaski, D., Yong, K., Patterson, R., Slattery, C., Ryan, N., ...Crutch, S. (2015). ABNORMALITIES OF FIXATION, SACCADE AND PURSUIT IN POSTERIOR CORTICAL ATROPHY.
Shakespeare, T.J., Kaski, D., Yong, K.X., Paterson, R.W., Slattery, C.F., Ryan, N.S., ...Crutch, S.J. (2015). Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy.. Brain, 138 1976-1991. doi:10.1093/brain/awv103
Andrews, K.A., Frost, C., Modat, M., Cardoso, M.J., Rowe, C.C., Villemagne, V., ...Schott, J.M. (2015). Acceleration of hippocampal atrophy rates in asymptomatic amyloidosis. Neurobiology of Aging, 39 99-107. doi:10.1016/j.neurobiolaging.2015.10.013
Cash, D.M., Frost, C., Iheme, L.O., Ünay, D., Kandemir, M., Fripp, J., ...Fischl, B. (2015). Assessing atrophy measurement techniques in dementia: Results from the MIRIAD atrophy challenge. Neuroimage, 123 149-164. doi:10.1016/j.neuroimage.2015.07.087
Fletcher, P.D., Downey, L.E., Golden, H.L., Clark, C.N., Slattery, C.F., Paterson, R.W., ...Warren, J.D. (2015). Auditory hedonic phenotypes in dementia: A behavioural and neuroanatomical analysis. Cortex, 67 95-105. doi:10.1016/j.cortex.2015.03.021
Golden, H.L., Nicholas, J.M., Yong, K.X.X., Downey, L.E., Schott, J.M., Mummery, C.J., ...Warren, J.D. (2015). Auditory spatial processing in Alzheimer's disease.. Brain, 138 (1), 189-202. doi:10.1093/brain/awu337
Skillback, T., Farahmand, B.Y., Rosen, C., Mattsson, N., Nagga, K., Kilander, L., ...Schott, J.M. (2015). Cerebrospinal fluid tau and amyloid-beta(1-42) in patients with dementia. BRAIN, 138 2716-2731. doi:10.1093/brain/awv181
Zandi, M.S., Paterson, R.W., Ellul, M.A., Jacobson, L., Al-Diwani, A., Jones, J.L., ...Bhatia, K.P. (2015). Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes.. J. Neurol. Neurosurg. Psychiatr., 86 (7), 708-713.
Fletcher, P.D., Nicholas, J.M., Shakespeare, T.J., Downey, L.E., Golden, H.L., Agustus, J.L., ...Crutch, S.J. (2015). Dementias show differential physiological responses to salient sounds.. Front Behav Neurosci, 9 doi:10.3389/fnbeh.2015.00073
Manning, E.N., Macdonald, K.E., Leung, K.K., Young, J., Pepple, T., Lehmann, M., ...Ourselin, S. (2015). Differential hippocampal shapes in posterior cortical atrophy patients: A comparison with control and typical AD subjects. Human Brain Mapping, n/a. doi:10.1002/hbm.22999
Paterson, R.W., Toombs, J., Slattery, C.F., Nicholas, J.M., Andreasson, U., Magdalinou, N.K., ...Rossor, M.N. (2015). Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis. JOURNAL OF NEUROLOGY, 262 (12), 2722-2730. doi:10.1007/s00415-015-7904-3
Paterson, R.W., Toombs, J., Chapman, M.D., Nicholas, J.M., Heslegrave, A.J., Slattery, C.F., ...Weston, P.S.J. (2015). Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 1 (3), 380-384. doi:10.1016/j.dadm.2015.06.003
Schmidt, R., Hofer, E., Bouwman, F.H., Buerger, K., Cordonnier, C., Fladby, T., ...Hort, J. (2015). EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. EUROPEAN JOURNAL OF NEUROLOGY, 22 (6), 889-898. doi:10.1111/ene.12707
Mota, A., Cuplov, V., Drobnjak, I., Dickson, J., Bert, J., Burgos, N., ...Schott, J. (2015). Erratum to: Establishment of an open database of realistic simulated data for evaluation of partial volume correction techniques in brain PET/MR(EJNMMI Physics).
Mota, A., Cuplov, V., Schott, J., Hutton, B., Thielemans, K., Drobnjak, I., ...Cardoso, J. (2015). Establishment of an open database of realistic simulated data for evaluation of partial volume correction techniques in brain PET/MR..
Golden, H.L., Agustus, J.L., Goll, J.C., Downey, L.E., Mummery, C.J., Schott, J.M., ...Warren, J.D. (2015). Functional neuroanatomy of auditory scene analysis in Alzheimer's disease. Neuroimage: Clinical, 7 699-708. doi:10.1016/j.nicl.2015.02.019
Ryan, N.S., Biessels, G.-.J., Kim, L., Nicholas, J.M., Barber, P.A., Walsh, P., ...Schott, J.M. (2015). Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease. NEUROBIOLOGY OF AGING, 36 (12), 3140-3151. doi:10.1016/j.neurobiolaging.2015.08.026
Clark, C.N., Nicholas, J.M., Henley, S.M., Downey, L.E., Woollacott, I.O., Golden, H.L., ...Rohrer, J.D. (2015). Humour processing in frontotemporal lobar degeneration: A behavioural and neuroanatomical analysis. Cortex, 69 47-59. doi:10.1016/j.cortex.2015.03.024
Golden, H.L., Downey, L.E., Fletcher, P.D., Mahoney, C.J., Schott, J.M., Mummery, C.J., ...Warren, J.D. (2015). Identification of environmental sounds and melodies in syndromes of anterior temporal lobe degeneration. Journal of the Neurological Sciences, 352 (1-2), 94-98. doi:10.1016/j.jns.2015.03.007
Golden, H.L., Downey, L.E., Fletcher, P.D., Mahoney, C.J., Schott, J.M., Mummery, C.J., ...Warren, J.D. (2015). Identification of environmental sounds and melodies in syndromes of anterior temporal lobe degeneration. Journal of the Neurological Sciences, 352 (1-2), 94-98. doi:10.1016/j.jns.2015.03.007
Heywood, W.E., Galimberti, D., Bliss, E., Sirka, E., Paterson, R.W., Magdalinou, N.K., ...Fenoglio, C. (2015). Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay. Molecular Neurodegeneration, 10 doi:10.1186/s13024-015-0059-y
Schott, J.M. (2015). Infection, inflammation and Alzheimer's disease.. EUROPEAN JOURNAL OF NEUROLOGY, 22 (12), 1503-1504. doi:10.1111/ene.12522
Burgos, N., Cardoso, M.J., Thielemans, K., Modat, M., Dickson, J., Schott, J., ...Ourselin, S. (2015). Multi-contrast attenuation map synthesis for PET/MR scanners: assessment on FDG and Florbetapir PET tracers. European Journal of Nuclear Medicine and Molecular Imaging, 42 (9), 1447-1458. doi:10.1007/s00259-015-3082-x
Young, A.L., Oxtoby, N.P., Huang, J., Marinescu, R.V., Daga, P., Cash, D.M., ...Alexander, D.C. (2015). Multiple orderings of events in disease progression.
Schott, J.M., Petersen, R.C. (2015). New criteria for Alzheimer's disease: which, when and why?. BRAIN, 138 1134-1137. doi:10.1093/brain/awv055
McColgan, P., Viegas, S., Gandhi, S., Bull, K., Tudor, R., Sheikh, F., ...Gillmore, J.D. (2015). Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.. J Neurol, 262 (1), 228-234. doi:10.1007/s00415-014-7594-2
Fletcher, P.D., Downey, L.E., Golden, H.L., Clark, C.N., Slattery, C.F., Paterson, R.W., ...Warren, J.D. (2015). Pain and temperature processing in dementia: a clinical and neuroanatomical analysis. Brain: a journal of neurology, 138 (11), 3360-3372. doi:10.1093/brain/awv276
Dickson, J.C., Erlandsson, K., Lehmann, M., Modat, M., Burgos, N., Groves, A., Schott, J. (2015). Partial Volume Correction of Amyvid and FDG PET data using the discrete iterative Yang technique.
Slattery, C.F., Crutch, S.J., Schott, J.M. (2015). Phenotypical variation in Alzheimer's disease: insights from posterior cortical atrophy.. Practical Neurology, 15 (1), 2-4. doi:10.1136/practneurol-2014-000955
Fletcher, P.D., Nicholas, J.M., Shakespeare, T.J., Downey, L.E., Golden, H.L., Agustus, J.L., ...Crutch, S.J. (2015). Physiological phenotyping of dementias using emotional sounds. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 1 (2), 170-178. doi:10.1016/j.dadm.2015.02.003
Slattery, C.F., Schott, J.M. (2015). Picturing the torment of cluster headache.. Neurology, 85 (16), 1430-1431. doi:10.1212/WNL.0000000000002042
Yong, K.X.X., Shakespeare, T.J., Cash, D., Henley, S.M.D., Nicholas, J.M., Ridgway, G.R., ...Kaski, D. (2015). Prominent effects and neural correlates of visual crowding in a neurodegenerative disease population (vol 137, pg 3284, 2014). BRAIN, 138 E345. doi:10.1093/brain/awv033
Burgos, N.F., Cardoso, M.J., Mendelson, A.F., Schott, J.M., Atkinson, D., Arridge, S.R., ...Ourselin, S. (2015). Subject-specific Models for the Analysis of Pathological FDG PET Data.
Bocchetta, M., Gordon, E., Marshall, C.R., Slattery, C.F., Cardoso, M.J., Cash, D.M., ...Frisoni, G.B. (2015). The habenula: an under-recognised area of importance in frontotemporal dementia?. Journal of Neurology, Neurosurgery and Psychiatry, doi:10.1136/jnnp-2015-312067
Toombs, J., Paterson, R.W., Nicholas, J.M., Petzold, A., Schott, J.M., Zetterberg, H. (2015). The impact of Tween 20 on repeatability of amyloid beta and tau measurements in cerebrospinal fluid. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 53 (12), E329-E332. doi:10.1515/cclm-2015-0414
Magdalinou, N., Ling, H., Noyce, A., Massey, L., Paterson, R., Schott, J., ...Warner, T. (2015). The visual estimation of midbrain to pons ratio combined with cerebrospinal fluid biomarkers improves the diagnostic accuracy of PSP.
Weston, P.S.J., Paterson, R.W., Lehmann, M., Modat, M., Bomanji, J.B., Kayani, I., ...Ourselin, S. (2015). USING FLORBETAPIR PET TO INCREASE DIAGNOSTIC CERTAINTY IN ATYPICAL DEMENTIAS.
Weston, P.S., Paterson, R.W., Modat, M., Burgos, N., Cardoso, M.J., Magdalinou, N., ...Bomanji, J.B. (2015). Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 1 (4), 440-446. doi:10.1016/j.dadm.2015.10.001
Harper, L., Barkhof, F., Fox, N.C., Schott, J.M. (2015). Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 86 (11), 1225-1233. doi:10.1136/jnnp-2014-310090
Downey, L.E., Mahoney, C.J., Buckley, A.H., Golden, H.L., Henley, S.M., Schmitz, N., ...Fox, N.C. (2015). White matter tract signatures of impaired social cognition in frontotemporal lobar degeneration. Neuroimage Clinical, 8 640-651. doi:10.1016/j.nicl.2015.06.005

2014

Young, A.L., Oxtoby, N.P., Daga, P., Cash, D.M., Fox, N.C., Ourselin, S., ...Alzheimer’s Disease Neuroimaging, I.n.i.t.i.a.t.i.v.e. (2014). A data-driven model of biomarker changes in sporadic Alzheimer's disease.. Brain, 137 (9), 2564-2577. doi:10.1093/brain/awu176
Ahmed, R.M., Murphy, E., Davagnanam, I., Parton, M., Schott, J.M., Mummery, C.J., ...Fox, N.C. (2014). A practical approach to diagnosing adult onset leukodystrophies. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85 (7), 770-781. doi:10.1136/jnnp-2013-305888
Kaski, D., Shakespeare, T., Schott, J., Crutch, S. (2014). Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy.
Kaski, D., Shakespeare, T., Schott, J., Crutch, S. (2014). Abnormalities of fixation, saccade and pursuit in posterior cortical atrophy. EUROPEAN JOURNAL OF NEUROLOGY, 21 19.
Merwick, A., Ahmed, R., Murphy, E., Davagnanam, I., Schott, J., Mummery, C., ...Chataway, J. (2014). ADULT LEUKODYSTROPHY: MULTI-DISCIPLINARY STRUCTURED APPROACH.
Downey, L.E., Fletcher, P.D., Golden, H.L., Mahoney, C.J., Agustus, J.L., Schott, J.M., ...Rossor, M.N. (2014). Altered body schema processing in frontotemporal dementia with C9ORF72 mutations.. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85 (9), 1016-1023. doi:10.1136/jnnp-2013-306995
Toombs, J., Paterson, R.W., Schott, J.M., Zetterberg, H. (2014). Amyloid-beta 42 adsorption following serial tube transfer.. ALZHEIMERS RESEARCH & THERAPY, 6 (1), doi:10.1186/alzrt236
Harper, L., Barkhof, F., Scheltens, P., Schott, J.M., Fox, N.C. (2014). An algorithmic approach to structural imaging in dementia. Journal of Neurology, Neurosurgery and Psychiatry, 85 (6), 692-698. doi:10.1136/jnnp-2013-306285
Harper, L., Barkhof, F., Scheltens, P., Schott, J.M., Fox, N.C. (2014). An algorithmic approach to structural imaging in dementia.. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85 (6), 692-698. doi:10.1136/jnnp-2013-306285
Burgos, N., Cardoso, M.J., Thielemans, K., Modat, M., Pedemonte, S., Dickson, J., ...Schott, J.M. (2014). Attenuation correction synthesis for hybrid PET-MR scanners: application to brain studies.. IEEE Trans Med Imaging, 33 (12), 2332-2341. doi:10.1109/TMI.2014.2340135
Paterson, R.W., Toombs, J., Slattery, C.F., Schott, J.M., Zetterberg, H. (2014). Biomarker modelling of early molecular changes in Alzheimer's disease.. MOLECULAR DIAGNOSIS & THERAPY, 18 (2), 213-227. doi:10.1007/s40291-013-0069-9
Ahmed, R.M., Paterson, R.W., Warren, J.D., Zetterberg, H., O'Brien, J.T., Fox, N.C., ...Schott, J.M. (2014). Biomarkers in dementia: clinical utility and new directions.. J Neurol Neurosurg Psychiatry, 85 (12), 1426-1434. doi:10.1136/jnnp-2014-307662
Paterson, R.W., Bartlett, J.W., Blennow, K., Fox, N.C., Alzheimer's Disease Neuroimaging, I.n.i.t.i.a.t.i.v.e., Shaw, L.M., ...Schott, J.M. (2014). Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.. Transl Psychiatry, 4 doi:10.1038/tp.2014.58
Paterson, R.W., Zandi, M.S., Armstrong, R., Vincent, A., Schott, J.M. (2014). Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: Experience from a tertiary referral centre. J. Neurol. Neurosurg. Psychiatr., 85 (6), 625-630.
Andreasson, U., Lautner, R., Schott, J.M., Mattsson, N., Hansson, O., Herukka, S.-.K., ...Wallin, A. (2014). CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.. MOLECULAR PSYCHIATRY, 19 (2), 148-149. doi:10.1038/mp.2013.18
Andreasson, U., Lautner, R., Schott, J.M., Mattsson, N., Hansson, O., Herukka, S.K., ...Wallin, A. (2014). CSF biomarkers for Alzheimer's pathology and the effect size of APOE ε4. Molecular Psychiatry, 19 (2), 148-149. doi:10.1038/mp.2013.18
Skillbäck, T., Farahmand, B., Bartlett, J.W., Rosén, C., Mattsson, N., Nägga, K., ...Winblad, B. (2014). CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.. NEUROLOGY, 83 (21), 1945-1953. doi:10.1212/WNL.0000000000001015
Clark, C., Nicholas, J., Henley, S., Downey, L., Golden, H., Fletcher, P., ...Warren, J. (2014). HUMOUR PROCESSING IN FRONTOTEMPORAL LOBAR DEGENERATIONS.
Schott, J.M. (2014). Immune mediated dementias.
Schott, J.M. (2014). Immune mediated dementias.
Oxtoby, N.P., Young, A.L., Fox, N.C., Daga, P., Cash, D.M., Ourselin, S., ......o.t.h.e.r.s. (2014). Learning imaging biomarker trajectories from noisy Alzheimer’s disease data using a Bayesian multilevel model.
Mahoney, C.J., Simpson, I.J.A., NIcholas, J.M., Fletcher, P.D., Downey, L.E., Golden, H.L., ...Schott, J.M. (2014). Longitudinal diffusion tensor imaging in frontotemporal dementia. Annals of Neurology, doi:10.1002/ana.24296
Jackson, G.S., Burk-Rafel, J., Edgeworth, J.A., Sicilia, A., Abdilahi, S., Korteweg, J., ...Schott, J.M. (2014). Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study.. JAMA NEUROLOGY, 71 (4), 421-428. doi:10.1001/jamaneurol.2013.6001
Mahoney, C.J., Ridgway, G.R., Malone, I.B., Downey, L.E., Beck, J., Kinnunen, K.M., ...Schott, J.M. (2014). Profiles of white matter tract pathology in frontotemporal dementia. Human Brain Mapping, 35 (8), 4163-4179. doi:10.1002/hbm.22468
Yong, K.X.X., Shakespeare, T.J., Cash, D., Henley, S.M.D., Nicholas, J.M., Ridgway, G.R., ...Kaski, D. (2014). Prominent effects and neural correlates of visual crowding in a neurodegenerative disease population.. Brain, 137 (Pt 12), 3284-3299. doi:10.1093/brain/awu293
Slattery, C.F., Beck, J.A., Harper, L., Adamson, G., Abdi, Z., Uphill, J., ...Rohrer, J.D. (2014). R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.. ALZHEIMERS & DEMENTIA, 10 (6), 602-608. doi:10.1016/j.jalz.2014.05.1751
Slattery, C., Beck, J., Harper, L., Adamson, G., Abdi, Z., Uphill, J., ...Rohrer, J. (2014). Trem2 variants increase risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 85 (8), doi:10.1136/jnnp-2014-308883.7
Beck, J., Pittman, A., Adamson, G., Campbell, T., Kenny, J., Houlden, H., ...Uphill, J. (2014). Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiology of Aging, 35 (1), 261-265. doi:10.1016/j.neurobiolaging.2013.07.017

2013

Fletcher, P.D., Downey, L.E., Agustus, J.L., Hailstone, J.C., Tyndall, M.H., Cifelli, A., ...Warren, J.D. (2013). Agnosia for accents in primary progressive aphasia.. Neuropsychologia, 51 (9), 1709-1715. doi:10.1016/j.neuropsychologia.2013.05.013
Andrews, K.A., Modat, M., Macdonald, K.E., Yeatman, T., Cardoso, M.J., Leung, K.K., ...Fox, N.C. (2013). Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials. PLoS ONE, 8 (3), e58816-. doi:10.1371/journal.pone.0058816
Pertzov, Y., Miller, T.D., Gorgoraptis, N., Caine, D., Schott, J.M., Butler, C., Husain, M. (2013). Binding deficits in memory following medial temporal lobe damage in patients with voltage-gated potassium channel complex antibody-associated limbic encephalitis.. BRAIN, 136 2474-2485. doi:10.1093/brain/awt129
Rohrer, J.D., Beck, J., Plagnol, V., Gordon, E., Lashley, T., Revesz, T., ...Rossor, M.N. (2013). Exome sequencing reveals a novel partial deletion in the progranulin gene causing primary progressive aphasia. Journal of Neurology, Neurosurgery and Psychiatry, 84 (12), 1411-1412. doi:10.1136/jnnp-2013-306116
Irani, S.R., Stagg, C.J., Schott, J.M., Rosenthal, C.R., Schneider, S.A., Pettingill, P., ...Voets, N.L. (2013). Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype.. BRAIN, 136 3151-3162. doi:10.1093/brain/awt212
Scahill, R.I., Ridgway, G.R., Barnes, J., Ryan, N.S., Clarkson, M.J., Foster, J., ...Warren, J.D. (2013). Genetic influences on atrophy patterns in familial AD: a comparason of APP and PSEN-1 mutations. Journal of AD, 35 199-212. doi:10.3233/JAD-121255
Schott, J.M. (2013). HIV testing in dementia: test some, perhaps more, but not all.. Practical Neurology, 13 (6), 357-358. doi:10.1136/practneurol-2013-000746
Toombs, J., Paterson, R.W., Lunn, M.P., Nicholas, J.M., Fox, N.C., Chapman, M.D., ...Zetterberg, H. (2013). Identification of an important potential confound in CSF AD studies: aliquot volume.. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 51 (12), 2311-2317. doi:10.1515/cclm-2013-0293
Liang, Y., Ryan, N.S., Schott, J.M., Fox, N.C. (2013). Imaging the onset and progression of Alzheimer's disease: Implications for prevention trials. Journal of Alzheimer's Disease, 33 (SUPPL. 1), doi:10.3233/JAD-2012-129010
Liang, Y., Ryan, N.S., Schott, J.M., Fox, N.C. (2013). Imaging the onset and progression of Alzheimer's disease: implications for prevention trials.. JOURNAL OF ALZHEIMERS DISEASE, 33 S305-S312. doi:10.3233/JAD-2012-129010
Schott, J.M., Revesz, T. (2013). Inflammation in Alzheimer's disease: insights from immunotherapy.. BRAIN, 136 2654-2656. doi:10.1093/brain/awt231
Beck, J., Poulter, M., Hensman, D., Rohrer, J.D., Mahoney, C.J., Adamson, G., ...Fratta, P. (2013). Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.. AMERICAN JOURNAL OF HUMAN GENETICS, 92 (3), 345-353. doi:10.1016/j.ajhg.2013.01.011
Rossor, M., Ahmed, R., Liang, Y., Douglas, J., Mahoney, C., Warren, J., ...Fox, N. (2013). LONGITUDINAL RESEARCH INTO ALZHEIMER'S DISEASE, FRONTO-TEMPORAL DEMENTIA AND OTHER DEMENTIAS.. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 84 (11), doi:10.1136/jnnp-2013-306573.68
Lambert, J.C., Ibrahim-Verbaas, C.A., Harold, D., Naj, A.C., Sims, R., Bellenguez, C., ...Grenier-Boley, B. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.. NATURE GENETICS, 45 (12), 1452-U206. doi:10.1038/ng.2802
Malone, I.B., Cash, D., Ridgway, G.R., MacManus, D.G., Ourselin, S., Fox, N.C., Schott, J.M. (2013). MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset.. NeuroImage, 70 (0), 33-36. doi:10.1016/j.neuroimage.2012.12.044
Warren, J.D., Rohrer, J.D., Schott, J.M., Fox, N.C., Hardy, J., Rossor, M.N. (2013). Molecular nexopathies: A new paradigm of neurodegenerative disease. Trends Neurosci, 36 (10), 561-569. doi:10.1016/j.tins.2013.06.007
Magdalinou, N.K., Ling, H., Smith, J.D.S., Schott, J.M., Watkins, L.D., Lees, A.J. (2013). Normal pressure hydrocephalus or progressive supranuclear palsy? A clinicopathological case series. Journal of Neurology, 260 (4), 1009-1013. doi:10.1007/s00415-012-6745-6
Crutch, S.J., Schott, J.M., Rabinovici, G.D., Boeve, B.F., Cappa, S.F., Dickerson, B.C., ...Lehmann, M. (2013). Shining a light on posterior cortical atrophy. Alzheimer's and Dementia, 9 (4), 463-465. doi:10.1016/j.jalz.2012.11.004
Crutch, S.J., Schott, J.M., Rabinovici, G.D., Boeve, B.F., Cappa, S.F., Dickerson, B.C., ...Lehmann, M. (2013). Shining a light on posterior cortical atrophy.. ALZHEIMERS & DEMENTIA, 9 (4), 463-465. doi:10.1016/j.jalz.2012.11.004
Barnes, J., Bartlett, J.W., Fox, N.C., Schott, J.M. (2013). Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials.. JOURNAL OF ALZHEIMERS DISEASE, 34 (2), 431-437. doi:10.3233/JAD-121936
Barnes, J., Carmichael, O.T., Leung, K.K., Schwarz, C., Ridgway, G.R., Bartlett, J.W., ...Biessels, G.J. (2013). Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.. Neurobiology of Aging, 34 (8), 1996-2002. doi:10.1016/j.neurobiolaging.2013.02.003
Lehmann, M., Koedam, E.L., Barnes, J., Bartlett, J.W., Barkhof, F., Wattjes, M.P., ...Fox, N.C. (2013). Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers. Neurobiology of Aging, 34 (1), 73-82. doi:10.1016/j.neurobiolaging.2012.03.010
Lehmann, M., Koedam, E.L., Barnes, J., Bartlett, J.W., Barkhof, F., Wattjes, M.P., ...Alzheimer's Disease Neuroimaging, I.n.i.t.i.a.t.i.v.e. (2013). Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers.. NEUROBIOLOGY OF AGING, 34 (1), 73-82. doi:10.1016/j.neurobiolaging.2012.03.010
McColgan, P., Viegas, S., Gandhi, S., Sheikh, F., Pinney, J., Fontana, M., ...Holton, J. (2013). WEIGHT LOSS, ENCEPHALOPATHY, URINARY DIFFICULTIES AND NUMB FEET IN A NIGERIAN MAN. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 84 (11), doi:10.1136/jnnp-2013-306573.139
Mahoney, C.J., Malone, I.B., Ridgway, G.R., Buckley, A.H., Downey, L.E., Golden, H.L., ...Rossor, M.N. (2013). White matter tract signatures of the progressive aphasias. Neurobiology of Aging,
Mahoney, C.J., Malone, I.B., Ridgway, G.R., Buckley, A.H., Downey, L.E., Golden, H.L., ...Rossor, M.N. (2013). White matter tract signatures of the progressive aphasias. NEUROBIOLOGY OF AGING, 34 (6), 1687-1699. doi:10.1016/j.neurobiolaging.2012.12.002

2012

Schott, J.M., Warren, J.D. (2012). Alzheimer's disease: mimics and chameleons.. Practical Neurology, 12 (6), 358-366. doi:10.1136/practneurol-2012-000315
Ryan, N.S., Bastos-Leite, A.J., Rohrer, J.D., Werring, D.J., Fox, N.C., Rossor, M.N., Schott, J.M. (2012). Cerebral microbleeds in familial Alzheimer's disease. BRAIN, 135 doi:10.1093/brain/awr126
Bartlett, J.W., Frost, C., Mattsson, N., Skillbäck, T., Blennow, K., Zetterberg, H., Schott, J.M. (2012). Determining cut-points for Alzheimers disease biomarkers: Statistical issues, methods and challenges. BIOMARKERS IN MEDICINE, 6 (4), 391-400. doi:10.2217/BMM.12.49
Mahoney, C., Beck, J., Rohrer, J., Lashley, T., Mok, K., Yeatman, T., ...Fox, N. (2012). Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.
Mahoney, C.J., Beck, J., Rohrer, J.D., Lashley, T., Mok, K., Shakespeare, T., ...Fox, N.C. (2012). Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.. Brain, 135 (3), 736-750. doi:10.1093/brain/awr361
Schrag, A., Schott, J.M. (2012). Images in clinical medicine. Kayser-Fleischer rings in Wilson's disease.. NEW ENGLAND JOURNAL OF MEDICINE, 366 (12), E18. doi:10.1056/NEJMicm1101534
Schrag, A., Schott, J.M. (2012). Images in clinical medicine. Kayser-Fleischer rings in Wilson's disease.. The New England journal of medicine, 366 (12), doi:10.1056/NEJMicm1101534
Schott, J.M., Bartlett, J.W. (2012). Investigating missing data in Alzheimer disease studies.. NEUROLOGY, 78 (18), 1370-1371. doi:10.1212/WNL.0b013e318253d66b
Schott, J.M., I.E.E.E. (2012). MRI BIOMARKERS IN NEURODEGENERATIVE DISORDERS.
Magdalinou, N.K., Ling, H., Schott, J.M., Lees, A.J. (2012). Normal pressure hydorcephalus or progressive supranuclear palsy? A clinicopathological case series.
Crutch, S.J., Lehmann, M., Schott, J.M., Rabinovici, G.D., Rossor, M.N., Fox, N.C. (2012). Posterior cortical atrophy.. Lancet Neurology, 11 (2), 170-178. doi:10.1016/S1474-4422(11)70289-7
Warren, J., Rohrer, J.D., Lashley, T., Schott, J.M., Beck, J., Mead, S., ...Rossor, M.N. (2012). The frontotemporal lobar degenerations as 'molecular nexopathies'.
Warren, J., Rohrer, J.D., Lashley, T., Schott, J.M., Beck, J., Mead, S., ...Rossor, M.N. (2012). The frontotemporal lobar degenerations as 'molecular nexopathies'.
Schott, J.M. (2012). Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging, 33 (7), 1486.e9-1486.e15. doi:10.1016/j.neurobiolaging.2011.02.008
Schott, J.M. (2012). Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. NEUROBIOLOGY OF AGING, 33 (7), doi:10.1016/j.neurobiolaging.2011.02.008
Schott, J.M. (2012). Voltage gated potassium channel complex antibody associated limbic encephalitis.
Schrag, A., Schott, J.M., Alzheimer's Disease Neuroimaging, I.n.i.t.i.a.t.i.v.e. (2012). What is the clinically relevant change on the ADAS-Cog?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83 (2), 171-173. doi:10.1136/jnnp-2011-300881
Schrag, A., Schott, J.M. (2012). What is the clinically relevant change on the ADAS-Cog?. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83 (3), doi:10.1136/jnnp-2011-301993.66
Ryan, N., Biessels, G., Bastos-Leite, A., Beck, J., Mead, S., Morris, H., ...Fox, N.C. (2012). WHITE MATTER LESIONS IN FAMILIAL ALZHEIMER'S DISEASE: EVIDENCE FOR INFLUENCE OF MUTATION POSITION ON AMYLOID ANGIOPATHY?.

2011

Fox, N.C., Ridgway, G.R., Schott, J.M. (2011). Algorithms, atrophy and Alzheimer's disease: Cautionary tales for clinical trials. NeuroImage, 57 (1), 15-18. doi:10.1016/j.neuroimage.2011.01.077
Fox, N.C., Ridgway, G.R., Schott, J.M. (2011). Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials.. NEUROIMAGE, 57 (1), 15-18. doi:10.1016/j.neuroimage.2011.01.077
Irani, S.R., Vincent, A., Schott, J.M. (2011). Autoimmune encephalitis. BRITISH MEDICAL JOURNAL, 342 doi:10.1136/bmj.d1918
Irani, S.R., Vincent, A., Schott, J.M. (2011). Autoimmune encephalitis.. BMJ, 343 (7818),
Revesz, T., Schott, J.M., Reiniger, L., Thom, M., Holton, J.L., Grieve, J., ...Warren, J.D. (2011). Brain biopsy in dementia: clinical indications and neuropathological diagnostic approach.
Rohrer, J.D., Lashley, T., Schott, J.M., Warren, J.E., Mead, S., Isaacs, A.M., ...Warrington, E. (2011). Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain, 134 (9), 2565-2581.
Irani, S.R., Michell, A.W., Johnson, M.R., Schott, J.M., Somerville, E.R., Vincent, A., Smith, S.M.J. (2011). Faciobrachial Dystonic Attacks: Seizures or Movement Disorder? Reply. ANNALS OF NEUROLOGY, 70 (1), 180. doi:10.1002/ana.22471
Irani, S.R., Michell, A.W., Lang, B., Pettingill, P., Waters, P., Johnson, M.R., ...Bleasel, A. (2011). Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Annals of Neurology, 69 (5), 892-900. doi:10.1002/ana.22307
Irani, S.R., Michell, A.W., Lang, B., Pettingill, P., Waters, P., Johnson, M.R., ...Bleasel, A. (2011). Faciobrachial Dystonic Seizures Precede Lgi1 Antibody Limbic Encephalitis. ANNALS OF NEUROLOGY, 69 (5), 892-900. doi:10.1002/ana.22307
Anderson, V., Schott, J., Bartlett, J., Leung, K.K., Miller, D.H., Fox, N.C. (2011). Grey matter atrophy rate as a marker of disease progression in AD. Neurobiology of Aging, doi:10.1016/j.neurobiolaging.2010.11.001
Schott, J.M. (2011). Limbic encephalitis. In Neuroimaging in Dementia. Springer Science & Business Media.
Schott, J.M., Warren, J.D., Rossor, M.N., Revesz, T. (2011). Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion.. NEUROLOGY, 76 (21), 1847. doi:10.1212/WNL.0b013e318210e621
Rohrer, J.D., Schott, J.M. (2011). Primary progressive aphasia-defining genetic and pathological subtypes. Curr Alzheimer Res, 8 (3), 266-272.
Schott, J.M., Warren, J.D., Barkhof, F., Rossor, M.N., Fox, N.C. (2011). RATIONAL IMAGING Suspected early dementia. BRITISH MEDICAL JOURNAL, 343 doi:10.1136/bmj.d5568
Irani, S.R., Michell, A.W., Johnson, M.R., Schott, J.M., Somerville, E.R., Vincent, A., Smith, S.M. (2011). Reply.. Annals of Neurology, 70 (1), 180-. doi:10.1002/ana.22471
Schott, J.M. (2011). Spectra to identify the spectre of Alzheimer disease?. NEUROLOGY, 77 (10), 932-933. doi:10.1212/WNL.0b013e31822cfce6
Schott, J.M., Warren, J.D., Barkhof, F., Rossor, M.N., Fox, N.C. (2011). Suspected early dementia. BMJ (Online), 343 (7824), doi:10.1136/bmj.d5568
Irani, S.R., Schott, J.M., Vincent, A., Smith, S.J.M. (2011). Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?. Neurology, 77 (24), 2140-2141. doi:10.1212/wnl.0b013e318239c3d7

2010

Revesz, T., Schott, J.M., Holton, J.L., Reiniger, L., Brandner, S., Thom, M., Warren, J.D. (2010). Brain biopsy in dementia - clinical indications and diagnostic approach.
Schott, J.M., Reiniger, L., Thom, M., Holton, J.L., Grieve, J., Brandner, S., ...Revesz, T. (2010). Brain biopsy in dementia: clinical indications and diagnostic approach.. ACTA NEUROPATHOLOGICA, 120 (3), 327-341. doi:10.1007/s00401-010-0721-y
Tolboom, N., Koedam, E.L.G.E., Schott, J.M., Yaqub, M., Blankenstein, M.A., Barkhof, F., ...van Berckel, B.N.M. (2010). Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings.. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 24 (3), 303-307. doi:10.1097/WAD.0b013e3181cf35ec
Guerreiro, R.J., Beck, J., Gibbs, J.R., Santana, I., Rossor, M.N., Schott, J.M., ...Fox, N.C. (2010). Genetic variability in CLU and its association with Alzheimer's disease.. PLOS ONE, 5 (3), doi:10.1371/journal.pone.0009510
Anderson, V.M., Schott, J.M., Bartlett, J.W., Leung, K.K., Miller, D.H., Fox, N.C. (2010). Gray matter atrophy rate as a marker of disease progression in AD. Neurobiology of Aging,
Schott, J.M., Bartlett, J.W., Fox, N.C., Barnes, J. (2010). Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Annals of Neurology, 68 (6), 825-834. doi:10.1002/ana.22315
Schott, J.M., Bartlett, J.W., Fox, N.C., Barnes, J., Alzheimer's Disease Neuroimaging Initiative, I.n.v.e.s.t.i.g.a.t.o.r.s. (2010). Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.. ANNALS OF NEUROLOGY, 68 (6), 825-834. doi:10.1002/ana.22315
Schott, J.M., Bartlett, J.W., Barnes, J., Leung, K.K., Ourselin, S., Fox, N.C. (2010). Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging, 31 (8), 1452-1462.e2.
Schott, J.M., Frost, C., MacManus, D.G., Ibrahim, F., Waldman, A.D., Fox, N.C. (2010). Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.. BRAIN, 133 3315-3322. doi:10.1093/brain/awq208
Rossor, M.N., Fox, N.C., Mummery, C.J., Schott, J.M., Warren, J.D. (2010). The diagnosis of young-onset dementia.. LANCET NEUROLOGY, 9 (8), 793-806. doi:10.1016/S1474-4422(10)70159-9

2009

Gutiérrez-Galve, L., Lehmann, M., Hobbs, N.Z., Clarkson, M.J., Ridgway, G.R., Crutch, S., ...Barnes, J. (2009). Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 28 (5), 476-485. doi:10.1159/000258100

2008

Barnes, J., Foster, J., Boyes, R.G., Pepple, T., Moore, E.K., Schott, J.M., ...Fox, N.C. (2008). A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. NeuroImage, 40 (4), 1655-1671. doi:10.1016/j.neuroimage.2008.01.012
Barnes, J., Scahill, R.I., Frost, C., Schott, J.M., Rossor, M.N., Fox, N.C. (2008). Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging. NEUROBIOLOGY OF AGING, 29 (8), 1199-1203. doi:10.1016/j.neurobiolaging.2007.02.011
Gilbert, G.J. (2008). Ischemic bilateral hippocampal dysfunction during transient global amnesia. NEUROLOGY, 70 (7), 580. doi:10.1212/01.wnl.0000304030.47603.20
Schott, J.M. (2008). Ischemic bilateral hippocampal dysfunction during transient global amnesia.. NEUROLOGY, 70 (20), 1940. doi:10.1212/01.wnl.0000314641.73292.d3
Schott, J.M., Crutch, S.J., Frost, C., Warrington, E.K., Rossor, M.N., Fox, N.C. (2008). Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia, 46 (6), 1732-1737. doi:10.1016/j.neuropsychologia.2008.02.015
Gallagher, D.A., Schott, J.M., Childerhouse, A., Wilhelm, T., Gale, A.N., Schrag, A. (2008). Reversible "Applause sign" secondary to diffuse large B cell lymphoma. Movement Disorders, 23 (16), 2426-2428. doi:10.1002/mds.22311

2007

Gallagher, D.A., Schott, J.M., Childerhouse, A., Wilhelm, T., Gale, A., Schrag, A. (2007). "Applause Sign" secondary to infiltrative cerebral lymphoma.
Schott, J.M. (2007). A neurological MRI menagerie. Practical Neurology, 7 (3), 186-190. doi:10.1136/jnnp.2007.120261
Ridha, B.H., Barnes, J., van de Pol, L.A., Schott, J.M., Boyes, R.G., Siddique, M.M., ...Fox, N.C. (2007). Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Archives of Neurology, 64 (6), 849-854. doi:10.1001/archneur.64.6.849
Barnes, J., Lewis, E.B., Scahill, R.I., Bartlett, J.W., Frost, C., Schott, J.M., ...Fox, N.C. (2007). Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls. Journal of Computer Assisted Tomography, 31 (4), 581-587.
Barnes, J., Boyes, R.G., Lewis, E.B., Schott, J.M., Frost, C., Scahill, R.I., Fox, N.C. (2007). Automatic calculation of hippocampal atrophy rates using a hippocampal template and boundary shift integral.. Neurobiology of Aging, 28 (11), 1657-1663. doi:10.1016/j.neurobiolaging.2006.07.008
Smith, S.M., Rao, A., De Stefano, N., Jenkinson, M., Schott, J.M., Matthews, P.M., Fox, N.C. (2007). Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX. NeuroImage, 36 (4), 1200-1206. doi:10.1016/j.neuroimage.2007.04.035
Aram, J.A., Schott, J.M., Davies, G.R., Rabin, N., Ginsberg, L. (2007). POEMS syndrome mimicking systemic vasculitis.
Schott, J.M., Williams, D.R., Butterworth, R.J., Janssen, J.C., Larner, A.J., Holton, J.L., Rossor, M.N. (2007). Shunt responsive progressive supranuclear palsy?. Movement Disorders, 22 (6), 902-903. doi:10.1002/mds.21404
Schott, J.M., Warren, J.D. (2007). Steroid responsive encephalopathy with positive thyroid antibodies. A syndrome, not a diagnosis?. Journal of Neurology, 254 (4), 542-. doi:10.1007/s00415-006-0279-8
Schott, J.M., Fox, N.C. (2007). Structural imaging in the dementias. Psychiatry, 6 (12), 503-507. doi:10.1016/j.mppsy.2007.09.006

2006

Schott, J.M. (2006). Another case of voltage-gated potassium channel antibody-related encephalopathy?. European Neurology, 55 (2), 110. doi:10.1159/000092787
Schott, J.M., Ridha, B.H., Crutch, S.J., Healy, D.G., Uphill, J.B., Warrington, E.K., ...Fox, N.C. (2006). Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. Archives of Neurology, 63 (1), 155-156.
Boyes, R.G., Rueckert, D., Aljabar, P., Whitwell, J., Schott, J.M., Hill, D.L., Fox, N.C. (2006). Cerebral atrophy measurements using Jacobian integration: Comparison with the boundary shift integral. NeuroImage, 32 (1), 159-169.
Schott, J.M., Frost, C., Whitwell, J.L., MacManus, D.G., Boyes, R.G., Rossor, M.N., Fox, N.C. (2006). Combining short interval MRI in Alzheimer's disease : Implications for therapeutic trials. Journal of Neurology, 253 (9), 1147-1153.
Schrag, A., Schott, J.M. (2006). Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. The Lancet Neurology, 5 (4), 355-363.
Schott, J.M. (2006). Limbic encephalitis: a clinician's guide. Practical Neurology, 6 143-153.
Godbolt, A.K., Waldman, A.D., MacManus, D.G., Schott, J.M., Frost, C., Cipolotti, L., ...Rossor, M.N. (2006). MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology, 66 (5), 718-722.
Schott, J.M., Kennedy, J., Fox, N.C. (2006). New developments in mild cognitive impairment and Alzheimer's disease. Current Opinion in Neurology, 19 (6), 552-558.
Garrard, P., Schott, J.M., MacManus, D.G., Hodges, J.R., Fox, N.C., Waldman, A.D. (2006). Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia. Cognitive and Behavioral Neurology, 19 (4), pp.185-189.
Garrard, P., Schott, J.M., MacManus, D.G., Hodges, J.R., Fox, N.C., Waldman, A.D. (2006). Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia.. COGNITIVE AND BEHAVIORAL NEUROLOGY, 19 (4), 185-189. doi:10.1097/01.wnn.0000213915.72395.77
Schott, J.M., Williams, D.R., Butterworth, R., Janssen, J.C., Larner, A.J., Holton, J.L., Rossor, M.N. (2006). Shunt responsive progressive supranuclear palsy.

2005

Ridha, B.H., Schott, J.M., Crutch, S.J., Healy, D.G., Uphill, J.B., Warrington, E.W., ...Fox, N.C. (2005). Apoliprotein E genotype modifies the phenotype of Alzheimer's disease.
Warren, J.D., Schott, J.M., Fox, N.C., Thom, M., Revesz, T., Holton, J.L., ...Rudge, P. (2005). Brain biopsy in dementia. Brain, 128 (9), 2016-2025. doi:10.1093/brain/awh543
Schott, J.M., Warren, J.D., Fox, N.C., Thom, M., Revesz, T., Scaravilli, F., ...Rudge, P. (2005). Brain biopsy in dementia: A review of 90 consecutive cases from Queen Square.
Barnes, J., Scahill, R.I., Schott, J.M., Frost, C., Rossor, M.N., Fox, N.C. (2005). Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dementia and Geriatric Cognitive Disorders, 19 (5-6), 338-344.
Tashiro, K., Matsumoto, A., Moriwaka, F., Shima, K., Hamada, T. (2005). Etiology of mirror writing in Japanese. ARCHIVES OF NEUROLOGY, 62 (5), 834-835. doi:10.1001/archneur.62.5.834-b
Schott, G.D., Schott, J.M. (2005). Etiology of mirror writing in Japanese - In reply. Archives of Neurology, 62 (5), 835.
Malik, S., Schott, J., Ali, S.W., Oeffner, F., Amin-ud-Din, M., Ahmad, W., ...Koch, M.C. (2005). Evidence for clinical and genetic heterogeneity of syndactyly type I: the phenotype of second and third toe syndactyly maps to chromosome 3p21.31. EUROPEAN JOURNAL OF HUMAN GENETICS, 13 (12), 1268-1274. doi:10.1038/sj.ejhg.5201492
Archer, H.A., Schott, J.M., Barnes, J., Fox, N.C., Holton, J.L., Revesz, T., ...Rossor, M.N. (2005). Knight's move thinking? Mild cognitive impairment in a chess player. Neurocase, 11 (1), 26-31.
Janssen, J.C., Schott, J.M., Cipolotti, L., Fox, N.C., Scahill, R.I., Josephs, K.A., ...Rossor, M.N. (2005). Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery and Psychiatry, 76 (2), 162-168.
Schott, J.M., Price, S.L., Frost, C., Whitwell, J.L., Rossor, M.N., Fox, N.C. (2005). Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology, 65 (1), 119-124.

2004

Schott, J.M., Harkness, K., Barnes, J., della Rocchetta, A.I., Vincent, A., Rossor, M.N. (2004). Amnesia, cerebral atrophy, and autoimmunity (vol 361, pg 1266, 2003). LANCET, 363 (9402), 86.
Whitwell, J.L., Schott, J.M., Watt, H.C., Crum, W.R., Rossor, M.N., Fox, N.C. (2004). Correcting brain volumes for total intracranial volume: Applications in serial studies of Alzheimer's disease.
Mahapatra, R.K., Edwards, M.J., Schott, J.M., Bhatia, K.P. (2004). Corticobasal degeneration. The Lancet Neurology, 3 (12), 736-743.
Schott, J.M., Lees, A.J., Rossor, M.N. (2004). Dementia in dementia with Lewy bodies may not be attributable to Alzheimer pathology. Annals of Neurology, 56 (4), 604. doi:10.1002/ana.20271
Chan, D., Walters, R.J., Sampson, E.L., Schott, J.M., Smith, S.J., Rossor, M.N. (2004). EEG abnormalities in frontotemporal lobar degeneration. Neurology, 62 (9), 1628-1630.
Schott, J.M., Fox, N.C., Frost, C., Scahill, R.I., Chan, D., Janssen, J.C., ...Rossor, M.N. (2004). Familial Alzheimer's disease: How early does medial temporal lobe atrophy occur?.
Scahill, R.I., Schott, J.M., Stevens, J.M., Janssen, J.C., Rossor, M.N., Fox, N.C. (2004). Fluid registration of serial MRI: Identifying regional changes in Alzheimer's disease.
Fox, N.C.I., Schott, J.M. (2004). Imaging cerebral atrophy: normal ageing to Alzheimer's disease. The Lancet, 363 (9406), 392-394. doi:10.1016/S0140-6736(04)15441-X
Boyes, R.G., Schott, J.M., Frost, C., Fox, N.C. (2004). Increasing accuracy of atrophy measures from serial MR scans using parameter analysis of the boundary shift integral. Lecture Notes In Computer Science, 3217 1036-1037.
Fox, N.C., Schott, J.M., Scahill, R.I. (2004). Measuring progression in Alzheimer's disease using serial MRI: 4D MRI. In Hyman, B., Demonet, J.F., Christen, Y. (Eds.), The Living Brain and Alzheimer's Disease. (pp. 61-74). Heidelberg: Springer-Verlag.
Schott, G.D., Schott, J.M. (2004). Mirror writing, left-handedness, and leftward scripts. Archives of Neurology, 61 (12), 1849-1851.
Fox, N., Schott, J., Barnes, J., Price, S., Anderson, V., Whitwell, J., Rossor, M. (2004). MRI to measure progression to AD and in AD.
Paviour, D.C., Schott, J.M., Stevens, J.M., Revesz, T., Holton, J.L., Rossor, M.N., ...Fox, N.C. (2004). Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry, 75 (12), 1772-1775.
Schott, J.M., Vincent, A., Clover, L., Buckley, C., Gabel, A., Lang, B., ...Rossor, M.N. (2004). Potassium channel antibody associated encephalitis: A potentially treatable non-paraneoplastic limbic encephalitis.
Vincent, A., Buckley, C., Schott, J.M., Baker, I., Dewar, B.K., Detert, N., ...Omer, S. (2004). Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain, 127 (3), 701-712.
Schott, J.M., Frost, C., Crutch, S.J., Boyes, R.G., Whitwell, J.L., Scahill, R.I., ...Fox, N.C. (2004). Predictors and correlates of inter-individual variation in MRI derived atrophy rates in Alzheimer's disease.
Schott, J.M., Janssen, J.C., Cipolotti, L., Fox, N.C., Scahill, R.I., Josephs, K.A., ...Rossor, M.N. (2004). Presymptomatic focal atrophy precedes speech production impairment in familial frontotemporal lobar degeneration.
Fox, N.C., Schott, J.M., Frost, C., Rossor, M.N. (2004). Serial magnetic resonance imaging as an outcome measure in dementia.
Schott, J.M., Fox, N.C. (2004). Structural imaging in the dementias. Psychiatry, 3 (12), 22-26. doi:10.1383/psyt.3.12.22.56779
Whitwell, J.L., Schott, J.M., Lewis, E.B., MacManus, D.G., Fox, N.C. (2004). Using nine degrees-of-freedom registration to correct for changes in voxel size in serial MRI studies. Magnetic Resonance Imaging, 22 (7), 993-999.

2003

Schott, J.M., Harkness, K., Barnes, J., Della Rocchetta, A.I., Vincent, A., Rossor, M.N. (2003). Amnesia, cerebral atrophy, and autoimmunity. The Lancet, 361 (9365), 1266. doi:10.1016/S0140-6736(03)12983-2
Schott, J.M., Fox, N.C., Frost, C., Scahill, R.I., Janssen, J.C., Chan, D., ...Rossor, M.N. (2003). Assessing the onset of structural change in familial Alzheimer's disease. Annals of Neurology, 53 (2), 181-188. doi:10.1002/ana.10424
Schott, J.M., Simon, J.E., Fox, N.C., King, A.P., Khan, M.N., Cipolotti, L., ...Rossor, M.N. (2003). Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. Movement Disorders, 18 (8), 955-958.
Schott, J.M., Crutch, S.J., Fox, N.C., Warrington, E.K. (2003). Development of selective verbal memory impairment secondary to a left thalamic infarct: a longitudinal case study. Journal of Neurology, Neurosurgery and Psychiatry, 74 (2), 255-257.
Schott, J.M., Fox, N.C., Rossor, M.N. (2003). Erratum: Genetics of the dementias (Journal of Neurology, Neurosurgery and Psychiatry (2002) 73, suppl II (ii27-ii31)). Journal of Neurology, Neurosurgery and Psychiatry, 74 (SUPPL. 2),
Fender, M., Schott, J., Baldauf, J.J., Muller, J., Schlund, E., Dellenbach, P. (2003). EVE, a regional campaign for the screening of cervical cancer - Organisation, 7-years results and perspectives. PRESSE MEDICALE, 32 (33), 1545-1551.
Kunze, S., Reichelt, S., Rossa, K., Schott, J. (2003). Gender-based health aspects of elderly citizens in outpatient care.
Schott, J., Richter, A. (2003). Mortality tables with causes of death for Saxony 1980-1998.
Schott, J.M., Paviour, D.C., Fox, N.C., Stevens, J.M., Lees, A.J., Rossor, M.N. (2003). Picturing the atrophy patterns of progressive supranuclear palsy and multiple system atrophy in vivo using fluid registered MRI.
Schott, J.M., Rossor, M.N. (2003). The grasp and other primitive reflexes. Journal of Neurology, Neurosurgery and Psychiatry, 74 (5), 558-560.
Schott, J.M., Warren, J.D., Rossor, M.N. (2003). The uncertain nosology of ‘Hashimoto’s encephalopathy’. Archives of Neurology, 60 1812-.
Walters, R.J.L., Fox, N.C., Schott, J.M., Crum, W.R., Stevens, J.M., Rossor, M.N., Thomas, D.J. (2003). Transient ischaemic attacks are associated with increased rates of global cerebral atrophy. Journal of Neurology, Neurosurgery and Psychiatry, 74 (2), 213-216.
Vincent, A., Clover, L., Schott, J., Buckley, C., Gabel, A., Omer, S., ...Rossor, M. (2003). Voltage-gated potassium channel antibody associated limbic encephalitis is relatively common, potentially treatable, and usually nonaraneoplastic.

2002

Schott, J., Westerinen, A., Martin-Flatin, J.P., Rivera, P. (2002). Common information vs. information overload.
Schott, J., Fox, N., Frost, C., Scahill, R., Chan, D., Janssen, J., ...Rossor, M. (2002). Familial Alzheimer's disease: How early does medial temporal lobe atrophy occur.
Schott, J.M., Fox, N.C., Rossor, M.N. (2002). Genetics of the dementias.. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73 27-31.
Janssen, J.C., Scahill, R.I., Schott, J.M., Whitwell, J., Warrington, E., Rossor, M.N., ...Cipolotti, L. (2002). In vivo mapping of the onset and progression of neurodegeneration in frontotemporal lobar degeneration. NEUROBIOLOGY OF AGING, 23 (1), S479.
Scahill, R.I., Schott, J.M., Rossor, M.N., Fox, N.C., Stevens, J.M. (2002). Mapping the evolution of regional atrophy in Alzheimer's disease: Unbiased analysis of fluid-registered serial magnetic resonance images. NEUROBIOLOGY OF AGING, 23 (1), S420-S421.
Scahill, R.I., Schott, J.M., Stevens, J.M., Rossor, M.N., Fox, N.C. (2002). Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proceedings of the National Academy of Sciences of the United States of America, 99 (7), 4703-4707. doi:10.1073/pnas.052587399
Schott, J.M., Scahill, R.I., Stevens, J.M., Rossor, M.N. (2002). Mapping the evolution of regional atrophy of regional atrophy in Alzheimer's disease using fluid registered MRI. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73 (2), 216.
Schott, J., Kyndt, F., Probst, V., Potet, F., Chevallier, J., Demolombe, S., ...Le Marec, H. (2002). Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large family.
Paviour, D.C., Schott, J.M., Fox, N.C., Stevens, J.M., Lees, A.J., Rossor, M.N. (2002). Picturing atrophy patterns of Progressive Supranuclear Palsy (PSP) in vivo using fluid registered MRI.

2001

Assmann, S., Haufe, E., Schott, J. (2001). Construction of a nonlinear social status score.

2000

Kunze, S., Bujantugs, L., Schott, J. (2000). Activating and rehabilitative aspects in inpatient geriatric care.
Kunze, S., Bujantugs, L., Schott, J. (2000). Activating and rehabilitative aspects in nursing homes.
Rigby, S.P., Schott, J.M., Bliss, P., Higgens, C.S., Kamm, M.A. (2000). Dilated stomach and weak muscles. Lancet, 356 (9245), 1898.
Hachey, D.M., Force, R.W., Schott, J., O'Leary-Jepsen, E. (2000). Indinavir crystalluria in an HIV-positive man. ANNALS OF PHARMACOTHERAPY, 34 (3), 403.

1999

Hirzinger, G., Landzettel, K., Brunner, B., Schaefer, I., Fischer, M., Grebenstein, M., ...Deutrich, C. (1999). DLR's robotics lab - Recent developments in space robotics.
Schott, J.M., Rigby, S.P., McNally, J.D., Keat, A., Higgens, C.S. (1999). Oral methotrexate: the hazard of different tablet strengths.. RHEUMATOLOGY, 38 (4), 382. doi:10.1093/rheumatology/38.4.382

1998

Hirzinger, G., Brunner, B., Landzettel, K., Schott, J. (1998). Preparing a new generation of space robots - A survey of research at DLR. ROBOTICS AND AUTONOMOUS SYSTEMS, 23 (1-2), 99-106. doi:10.1016/S0921-8890(97)00063-8

1997

Schott, J. (1997). Analysis of the strengths and weaknesses of Acid Rain electronic data reports.

1996

Brower, B.V., Hadcock, D.H., Reitz, J.P., Schott, J. (1996). Spectrally and spatially adaptive hyperspectral data compression.

1995

SMITH, W.B., THOMPSON, D.A., OLSON, J., SCHOTT, J. (1995). APPLICATION OF MULTI-SPECTRAL IMAGING SYSTEM ANALYSIS TO SURFACE TARGET DETECTION.
Rutherford, O.M., Beshyah, S.A., Schott, J., Watkins, Y., Johnston, D.G. (1995). Contractile properties of the quadriceps muscle in growth hormone-deficient hypopituitary adults.. CLINICAL SCIENCE, 88 (1), 67-71. doi:10.1042/cs0880067
Schott, J., Puttick, M. (1995). Handedness among surgeons.. BRITISH MEDICAL JOURNAL, 310 (6981), 739. doi:10.1136/bmj.310.6981.739b
GRIMM, H., TIBELL, A., NORRLIND, B., SCHOTT, J., BOHLE, R.M., PAPAVASSILIS, C., ...GRIMMINGER, F. (1995). IMMUNOSUPPRESSIVITY OF PARENTERAL FAT EMULSIONS UNDER DEFINED IMMUNOSTIMULATION. INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 22 (2), 110-116.
Schott, J., McCully, K., Rutherford, O.M. (1995). The role of metabolites in strength training. II. Short versus long isometric contractions.. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY AND OCCUPATIONAL PHYSIOLOGY, 71 (4), 337-341. doi:10.1007/BF00240414

1994

SCHOTT, J., RUTHERFORD, O.M. (1994). CHANGES IN FATIGUABILITY AND CONTRACTILE PROPERTIES OF THE HUMAN QUADRICEPS FOLLOWING ISOMETRIC STRENGTH TRAINING. JOURNAL OF PHYSIOLOGY-LONDON, 475P P26-P27.

1989

SCHOTT, J. (1989). ON THE DIFFERENCE IN THE NUMBER OF HUMAN-BEINGS WHO ON ACCOUNT OF AN ILLNESS WERE TREATED AND THOSE WHO ONLY WERE TAKEN CARE OF - A COGNITION-THEORETICAL PROBLEM IN THE EPIDEMIOLOGY OF CHRONIC-DEGENERATIVE DISEASES. ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 44 (15), 1335-1339.

1988

GROSSMAN, C., ROSELLE, G., MENDENHALL, C., DARPEL, J., SCHOTT, J. (1988). DEPRESSION OF THE INVIVO PHA SKIN-TEST BY SEX STEROIDS.

1987

RICHARDSON, J.L., SCHOTT, J., MCGUIGAN, K.A., LEVINE, A.M. (1987). BEHAVIOR-CHANGE AMONG HOMOSEXUAL COLLEGE-STUDENTS TO DECREASE THE RISK FOR ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME.

1982

SCHOTT, J., BERNER, R.A. (1982). XPS EVIDENCE FOR THE MECHANISM OF DISSOLUTION OF OLIVINES AND BRONZITE IN NATURE.

1979

SCHOTT, J. (1979). EPIDEMIOLOGY OF MALIGNANT NEOPLASMS OF THE BREAST, UTERINE CERVIX, ENDOMETRIUM, AND RECTUM OF FEMALES IN THE GDR, 1962-1972. ARCHIV FUR GESCHWULSTFORSCHUNG, 49 (1), 54-82.

1978

CABROL, P., COUDRAY, J., DANDURAND, J.L., SCHOTT, J. (1978). POSSIBLE TRANSFORMATION OF CALCITE TO ARAGONITE AT ORDINARY CONDITIONS OF TEMPERATURES AND CO2-PRESSURE - OBSERVATION ON CARBONATE DEPOSITS FROM CAVES AND EXPERIMENTALLY REPRODUCTION IN SOLUTIONS. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 287 (5), 411-&.
ZIGHELBOIM, J., SCHOTT, J., FAHEY, J.L. (1978). STIMULATION OF DNA-SYNTHESIS BY LEUKEMIA MYELOBLASTS IS INHIBITED BY ANTISERA TO HUMAN B-CELL ASSOCIATED ANTIGENS. LEUKEMIA RESEARCH, 2 (3), 223-230. doi:10.1016/0145-2126(78)90040-1

1977

SCHOTT, J. (1977). EPIDEMIOLOGY OF MALIGNANT NEOPLASMS IN GERMAN-DEMOCRATIC-REPUBLIC IN PERIOD OF 1962 TO 1972. ARCHIV FUR GESCHWULSTFORSCHUNG, 47 (1), 45-56.
COSTESEQUE, P., SCHOTT, J. (1977). EXPERIMENTS OF SYNTHESES OF CARBONATE MINERALS BY THERMAL-DIFFUSION IN POROUS-MEDIA. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 284 (12), 1005-1008.

1976

SCHOTT, J. (1976). MODEL FOR VALUATION OF MASS ATTENDANCE AND ATTENDANCE DURATION OF PATIENTS WITH MALIGNANT NEOPLASMS. ARCHIV FUR GESCHWULSTFORSCHUNG, 46 (1), 24-33.

1975

DANDURAND, J.L., SCHOTT, J. (1975). STABILITY OF NATURAL CARBONATES - EXPERIMENTAL OBSERVATIONS ON MAKING A SOLUTION OF SOME FINELY-GROUND CARBONATES - INTERPRETATION ATTEMPT. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 281 (1), 1-4.
SCHOTT, J., DANDURAND, J.L. (1975). STABILITY OF NATURAL CARBONATES - RE-EVALUATION OF FREE-ENERGY DATA IN SYSTEMS MGO-CO2-H2O AND CAO-MGO-CO2-H2O. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE C, 280 (20), 1247-1250.

1973

SCHOTT, J. (1973). MEASUREMENT OF SORET COEFFICIENTS BY THERMOGRAVITATIONAL METHOD - RESULTS OF STUDY ON SELECTIVITY OF NATURAL CRYSTALLIZATIONS. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE C, 276 (6), 459-462.

1972

SCHOTT, J. (1972). MEASUREMENT OF ORDINARY DIFFUSION-COEFFICIENTS OF IONIZED SALTS IN POROUS BEDS. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 275 (7), 795-&.

1971

ESTEBE, J., SCHOTT, J. (1971). NEW METHOD FOR DETERMINATION OF SORET COEFFICIENTS. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 272 (7), 905-&.
SCHOTT, J. (1971). POLITICS AND CHANGE IN DEVELOPING COUNTRIES - LEYS,C. AMERICAN JOURNAL OF SOCIOLOGY, 76 (4), 758-761. doi:10.1086/224987

1970

HANSEN, G., SCHOTT, J., JACOBASCH, G., RAPOPORT, S. (1970). ATTEMPTS AT MATHEMATIC DESCRIPTION OF INFLUENCE OF ATP AND F6P UPON HK-PFK SYSTEM IN ERYTHROCYTES AT PH 8.4. ACTA BIOLOGICA ET MEDICA GERMANICA, 24 (3), 253-+.
ESTEBE, J., SCHOTT, J. (1970). CONCENTRATION OF SALT SOLUTIONS AND CRYSTALLIZATION IN A POROUS MEDIUM BY A THERMOGRAVITATIONAL EFFECT. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES SERIE D, 271 (10), 805-&.

1957

VIVIEN, J.H., SCHOTT, J. (1957). ACTIVITE GONADOTROPE DES AUTOGREFFES ANTEHYPOPHYSAIRES CHEZ RANA-TEMPORARIA L. COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L ACADEMIE DES SCIENCES, 244 (9), 1263-1265.

1955

SCHOTT, J., JACOBI, M., WALD, M.A. (1955). ELECTROCARDIOGRAPHIC PATTERNS IN THE DIFFERENTIAL DIAGNOSIS OF PROGRESSIVE MUSCULAR DYSTROPHY. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 229 (5), 517-524. doi:10.1097/00000441-195505000-00007

1949

SCHOTT, J., DANN, S. (1949). WERNERS SYNDROME - A REPORT OF 2 CASES. NEW ENGLAND JOURNAL OF MEDICINE, 240 (16), 641-644. doi:10.1056/NEJM194904212401603

1900

Cash, D.M., Burgos, N., Modat, M., Dickson, J., Beasley, D., Markiewicz, P., ...Thomas, D.L. (1900). A COMPARISON OF TECHNIQUES FOR QUANTIFYING AMYLOID BURDEN ON A COMBINED PET/MR SCANNER. Presented at: Alzheimer's Association International Conference London, UK.
Pavisic, I., Primativo, S., Firth, N., Shakespeare, T., Yong, K., Slattery, C., ...Carton, A. (1900). Can eyetracking metrics relate to performance on visual cognitive tests of individuals with young onset Alzheimer’s disease?. Presented at: Alzheimer's Association International Conference 2017 London.
Paterson, R.W. (1900). Cerebrospinal fluid biomarkers in Alzheimer’s Disease: from bedside to bench and back. (Doctoral Dissertation). UCL Institute of Neurology.
Lashley, T., Walsh, P., Avery, A., Ryan, N., Crutch, S., Schott, J., Fox, N. (1900). Comparisons of pathological changes between amnestic Alzheimer’s disease and posterior cortical atrophy. Presented at: 13th International congress on Alzheimer’s and Parkinson’s disease. Vienna.
Veale, T., Malone, I.B., Poole, T., Parker, T.D., Slattery, C.F., Paterson, R.W., ...Zhang, H. (1900). Loss and Reorganisation of Superficial White Matter in Alzheimer's disease: A Diffusion MRI study. Cold Spring Harbor Laboratory.
Young, A.L., Oxtoby, N.P., Huang, J., Marinescu, R.V., Daga, P., Cash, D.M., ...Alexander, D.C. (1900). Multiple Orderings of Events in Disease Progression.
Wellington, H.C.D. (1900). Neurogranin - A Synaptic Biomarker of Alzheimer's Disease. (Doctoral Dissertation). UCL.
Walsh, P., Avery, A., Ryan, N., Crutch, S., Schott, J., Fox, N., Lashley, T. (1900). Patholoigcal comparisons between amnestic AD and its rarer variant posterior cortical atrophy. Presented at: UCL Neuroscience Symposium London.
Crutch, S.J., Lehmann, M., Schott, J.M., Rabinovici, G.D., Rossor, M.N., Fox, N.C. (1900). Posterior Cortical Atrophy. Lancet Neurology,
Foiani, M., Cicognola, C., Jackson-Morgan, T., Ermann, N., Woollacott, I., Heller, C., ...Ye, K. (1900). Searching for novel CSF biomarkers of primary tauopathies. Presented at: 11th International Conference on Frontotemporal Dementias .
O'Connor, A., Poole, T., Weston, P., Ryan, N., Liang, Y., Lu, K., ...Blennow, K. (1900). Serum neurofilament light concentration and progression in familial Alzheimer’s diseas. Presented at: Alzheimer's Association International Conference, 2018 Chicago, USA.
Arber, C., Toombs, J., Paterson, R., Ryan, N., V.i.l.l.e.g.a.s., Willumsen, N., ...Hardy, J. (1900). The full spectrum of ABeta fragments in iPSC-derived neurons and same-patient CSF. Presented at: Keystone Meeting USA.